Document:

exv4w2

 

EXHIBIT 4.2

REGISTRATION RIGHTS AGREEMENT

BY AND BETWEEN

GLOBAL INDUSTRIES, LTD,

AS ISSUER

AND

LEHMAN BROTHERS INC.,

AS REPRESENTATIVE OF THE SEVERAL

INITIAL PURCHASERS

DATED AS OF JULY 27, 2007

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	 	 	 	 	Page
	1.

	 	Definitions
	 	 	1	 
	2.

	 	Shelf Registration
	 	 	4	 
	3.

	 	Additional Interest
	 	 	6	 
	4.

	 	Registration Procedures
	 	 	7	 
	5.

	 	Registration Expenses
	 	 	12	 
	6.

	 	Indemnification and Contribution
	 	 	13	 
	7.

	 	Rule 144A
	 	 	15	 
	8.

	 	Participation in Underwritten Registrations
	 	 	15	 
	9.

	 	Selection of Underwriters
	 	 	16	 
	10.

	 	Miscellaneous
	 	 	16	 

 

 

1

          Registration Rights Agreement, dated as of July 27, 2007, by and among Global
Industries, Ltd., a Louisiana corporation (together with any successor entity, herein referred to
as the “Issuer”), and Lehman Brothers Inc., as representative of the several Initial Purchasers
(the “Initial Purchasers”).

          Pursuant to the Purchase Agreement, dated July 23, 2007, among the Issuer and the Initial
Purchasers (the “Purchase Agreement”), the Initial Purchasers have agreed to purchase from the
Issuer up to $325,000,000 aggregate principal amount 2.75% Senior Convertible Debentures due 2027
(the “Debentures”) (or up to $375,000,000 aggregate principal amount if the Initial Purchasers
exercise in full their option to purchase additional Debentures, as set forth in the Purchase
Agreement). The Debentures initially may be convertible into fully paid, nonassessable common
stock, $0.01 par value per share, of the Issuer (the “Common Stock”) on the terms, and subject to
the conditions, set forth in the Indenture (as defined herein). To induce the Initial Purchasers
to purchase the Debentures, the Issuer has agreed to provide the registration rights set forth in
this Agreement pursuant to the Purchase Agreement.

          The parties hereby agree as follows:

          1. Definitions. As used in this Agreement, the following capitalized terms shall have the
following meanings:

     Additional Interest: As defined in Section 3(a) hereof.

     Additional Interest Payment Date: Each February 1 and August 1, commencing February 1,
2008.

     Affiliate: As defined in Rule 405 under the Securities Act.

     Agreement: This Registration Rights Agreement, as amended, modified or otherwise
supplemented from time to time in accordance with the terms hereof.

     Broker-Dealer: Any broker or dealer registered under the Exchange Act.

     Business Day: A day other than a Saturday or Sunday or any day on which banking
institutions in The City of New York are authorized or obligated by law or executive order
to close.

     Closing Date: The date of this Agreement.

     Commission: Securities and Exchange Commission.

     Common Stock: As defined in the preamble hereto.

     Debentures: As defined in the preamble hereto.

     Effectiveness Period: As defined in Section 2(a)(iii) hereof.

 

2

     Effectiveness Target Date: As defined in Section 2(a)(ii) hereof.

     Exchange Act: Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission thereunder.

     Holder: A Person who owns, beneficially or otherwise, Transfer Restricted Securities.

     Indemnified Holder: As defined in Section 6(a) hereof.

     Indenture: The Indenture, dated as of July 27, 2007, among the Issuer and Wells Fargo
Bank, National Association, as trustee (the “Trustee”), pursuant to which the Debentures are
to be issued, as such Indenture is amended, modified or supplemented from time to time in
accordance with the terms thereof.

     Initial Purchasers: As defined in the preamble hereto.

     Issuer: As defined in the preamble hereto.

     Majority of Holders: Registered Holders of a number of shares of the then outstanding
Common Stock constituting Transfer Restricted Securities and an aggregate principal amount
of then outstanding Debentures constituting Transfer Restricted Securities, such that the
sum of such shares of Common Stock and the shares of Common Stock issuable upon conversion
of such Debentures constitute in excess of 50% of the sum of all of the then outstanding shares of Common Stock constituting Transfer Restricted Securities and the number of shares
of Common Stock issuable upon conversion of then outstanding Debentures constituting
Transfer Restricted Securities, in each case assuming that the Debentures are then
convertible and that no cash is paid upon a conversion of Debentures. For purposes of the
immediately preceding sentence, (i) any Holder may elect to make any request, notice,
demand, objection or other action hereunder with respect to all or any portion of Transfer
Restricted Securities held by it and only the portion as to which such action is taken shall
be included in the numerator of the fraction described in the preceding sentence and (ii)
Transfer Restricted Securities owned, directly or indirectly, by the Issuer or its
Affiliates shall be deemed not to be outstanding.

     NASD: National Association of Securities Dealers, Inc.

     New Securities: As defined in Section 10(d).

     Person: An individual, partnership, corporation, unincorporated organization, limited
liability company, trust, joint venture or a government or agency or political subdivision
thereof.

     Prospectus: The prospectus included in a Shelf Registration Statement (including,
without limitation, a prospectus that discloses information previously omitted from a
prospectus filed as part of an effective registration statement in reliance upon Rule 430A
promulgated pursuant to the Securities Act), as amended or supplemented by any

 

3

prospectus supplement and by all other amendments thereto, including post-effective amendments, and all
material incorporated by reference into such Prospectus.

     Purchase Agreement: As defined in the preamble hereto.

     Questionnaire: As defined in Section 2(b) hereof.

     Questionnaire Deadline: As defined in Section 2(b) hereof.

     Record Holder: With respect to any Additional Interest Payment Date, each Person who
is a Holder on the record date with respect to such Additional Interest Payment Date, which
record date shall be the January 15 and July 15 immediately preceding the relevant February
1 or August 1 Additional Interest Payment Date, respectively.

     Registration Default: As defined in Section 3(a) hereof.

     Securities Act: Securities Act of 1933, as amended, and the rules and resolutions of
the Commission thereunder.

     Shelf Registration Statement: As defined in Section 2(a)(i) hereof.

     Suspension Notice: As defined in Section 4(c) hereof.

     Suspension Period: As defined in Section 4(b)(i) hereof.

     TIA: Trust Indenture Act of 1939, as amended, and the rules and regulations of the
Commission thereunder, in each case, as in effect on the date the Indenture is qualified
under the TIA.

     Transfer Restricted Securities: Each of the Debentures and each of the shares of
Common Stock or New Securities issued upon conversion of Debentures until the earliest of:

     (i) the date on which holders (including any holders who have engaged in
hedging activities), other than Affiliates of the Issuer, of such Debentures or
such shares of Common Stock or New Securities issued upon conversion thereof may
sell or transfer all such securities immediately without restriction (including
without volume or manner of sale or filing restrictions) pursuant to Rule 144(k)
under the Securities Act (or any other similar provision then in force);

     (ii) the date on which all such Debentures or such shares of Common Stock or
New Securities issued upon conversion thereof has been effectively registered under
the Securities Act with the Shelf Registration Statement and sold pursuant thereto;
or

 

4

     (iii) the date when all such Debentures or such shares of Common Stock or New
Securities issued upon conversion have ceased to be outstanding (whether as a
result of repurchase and cancellation, conversion or otherwise).

     Underwritten Registration or Underwritten Offering: A registration in which Debentures
of the Issuer are sold to an underwriter for reoffering to the public.

          2. Shelf Registration.

          (a) The Issuer shall:

     (i) cause to be filed a registration statement pursuant to Rule 415 under the
Securities Act or any similar rule that may be adopted by the Commission, (the
“Shelf Registration Statement”), which Shelf Registration Statement shall provide
for the registration and resales on a continuous or delayed basis of all Transfer
Restricted Securities held by Holders that have provided the information required
pursuant to the terms of Section 2(b) hereof; provided that the Shelf Registration
Statement shall be an “automatic shelf registration statement” as defined under
Rule 405 under the Securities Act if the Issuer qualifies for its use;

     (ii) use its reasonable best efforts to cause the Shelf Registration Statement
to be declared effective under the Securities Act by the Commission not later than
180 days after the date hereof (the “Effectiveness Target Date”); and

     (iii) use its reasonable best efforts to keep the Shelf Registration Statement
continuously effective, supplemented and amended as required by the Securities Act
and by the provisions of Section 4(b) hereof to the extent necessary to ensure that
it (A) is available for resales by the Holders of Transfer Restricted Securities
entitled to the benefit of this Agreement and (B) conforms with the requirements of
this Agreement and the Securities Act for a period (the “Effectiveness Period”)
from the date the Shelf Registration Statement is declared effective by the
Commission until the earliest of:

     (1) the date when the Holders (including any Holders who have engaged
in hedging activities), other than Affiliates of the Issuer, are able to
sell all their Transfer Restricted Securities immediately without volume,
manner of sale, filing or other restriction under Rule 144(k) under the
Securities Act; or

     (2) the date when all of the Transfer Restricted Securities are
registered under the Shelf Registration Statement and sold pursuant thereto;
or

     (3) the date when all Transfer Restricted Securities have ceased to be
outstanding (whether as a result of repurchase and cancellation, conversion
or otherwise).

 

5

     The Issuer shall be deemed not to have used its reasonable best efforts to keep
the Shelf Registration Statement effective during the Effectiveness Period if it
voluntarily takes any action that would result in Holders of Transfer Restricted Securities not being able to offer and sell such Debentures at any time during
the Effectiveness Period, unless such action is (x) required by applicable law or
otherwise undertaken by the Issuer in good faith and for valid business reasons (not
including avoidance of the Issuer’s obligations hereunder), including the
acquisition or divestiture of assets, or (y) permitted by Section 4(b)(i) hereof.

          (b) To have its Transfer Restricted Securities included in the Shelf Registration Statement
pursuant to this Agreement, each Holder shall complete the Selling Securityholder Notice and
Questionnaire, the form of which is contained in Annex A to the Offering Memorandum relating to the
Debentures (the “Questionnaire”). The Issuer shall mail the Questionnaire to The Depositary Trust
Company (or a successor depositary of the Debentures) not less than 10 Business Days (but not more
than 40 Business Days) prior to the time the Issuer intends in good faith to have the Shelf
Registration Statement declared effective by the Commission. Holders are required to complete and
deliver the Questionnaire to the Issuer at least 10 Business Days prior to the effectiveness of the
registration statement (the “Questionnaire Deadline”) in order to be named as selling
securityholders in the Prospectus at the time that the Shelf Registration Statement is declared
effective. Upon receipt of a Questionnaire from a Holder on or prior to the Questionnaire
Deadline, the Issuer shall include such Holder’s Transfer Restricted Securities in the Shelf
Registration Statement and the Prospectus. In addition, promptly upon the request of a Holder given
to the Issuer at any time, the Issuer shall deliver a Questionnaire to such Holder. Any Holder
that does not complete and deliver a Questionnaire prior to the Questionnaire Deadline may not be
named as a selling securityholder in the Shelf Registration Statement at the time that it is
declared effective. Upon receipt of a completed Questionnaire from a Holder who did not complete
and deliver a Questionnaire prior to the Questionnaire Deadline, the Issuer shall, within 20
Business Days of such receipt, file such amendments to the Shelf Registration Statement or
supplements to a related Prospectus as are necessary to permit such Holder to deliver such
Prospectus to transferees of Transfer Restricted Securities; provided, that if a post-effective
amendment to the Shelf Registration Statement is required the Issuer shall not be obligated to file
more than one amendment for all such Holders in any one fiscal quarter unless the aggregate
principal amount of all Transfer Restricted Securities requested to be included in such amendment
or supplement by all such Holders exceeds $5,000,000.

          The Issuer will give notice to all selling Holders of the effectiveness of the Shelf
Registration Statement by issuing a press release to Business Wire or PR Newswire.

          (c) Upon receipt of written request for additional information from the Issuer, each Holder
who intends to be named as a selling securityholder in the Shelf Registration Statement shall
furnish to the Issuer in writing, within five Business Days after such Holder’s receipt of such
request, such additional information regarding such Holder and the proposed distribution by such
Holder of its Transfer Restricted Securities, in connection with the Shelf Registration Statement
or Prospectus or preliminary prospectus included therein and in any application to be filed with or
under state securities law, as the Issuer may reasonably request. In connection with all such
requests for information from Holders of Transfer Restricted Securities,

 

6

the Issuer shall notify such Holders of the requirements set forth in this paragraph regarding their obligation to provide
the information requested pursuant to this Section 2. Each Holder as to which the Shelf
Registration Statement is being effected agrees to furnish promptly to the Issuer all information required to be disclosed in order to make information previously furnished to
the Issuer by such Holder not materially misleading.

          3. Additional Interest.

          (a) If:

     (i) the Shelf Registration Statement has not filed and declared effective by
the Commission prior to or on the Effectiveness Target Date;

     (ii) except as provided in Section 4(b)(i) hereof, the Shelf Registration
Statement is filed and declared effective but, during the Effectiveness Period,
shall thereafter cease to be effective or fail to be usable for its intended
purpose without being succeeded within five Business Days by a post-effective
amendment to the Shelf Registration Statement, a supplement to the Prospectus or a
report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of
the Exchange Act that cures such failure and, in the case of a post-effective
amendment, is itself immediately declared effective; or

     (iii) (A) prior to or on the 45th or 60th day, as the
case may be, of any Suspension Period, such suspension has not been terminated or
(B) Suspension Periods exceed an aggregate of 90 days in any 360 day period,

(each such event referred to in foregoing clauses (i) through (iii), a “Registration Default”), the
Issuer hereby agrees to pay additional interest (“Additional Interest”) with respect to the
Debentures that are Transfer Restricted Securities from and including the day following the
Registration Default to but excluding the earlier of (1) the day on which the Registration Default
has been cured or (2) the second anniversary of the last day on which the Debentures were
originally issued; provided that if the two year period under Rule 144(k) under the Securities Act
is shortened, then the two-year period for the payment of additional interest shall be shortened to
the period when holders (including any holders who have engaged in hedging activities), other than
the Affiliates of the Issuer, of Transfer Restricted Securities are able to sell all such
Debentures immediately without restriction under Rule 144(k). Additional Interest, if any, will
accrue on the Debentures that are Transfer Restricted Securities at a rate, (x) with respect to the
first 90-day period during which a Registration Default shall have occurred and be continuing,
equal to 0.25% per annum of the principal amount of the Debentures, and (y) with respect to the
period commencing on the 91st day following the day the Registration Default shall have
occurred and be continuing, equal to 0.50% per annum of the principal amount of the Debentures;
provided that in no event shall Additional Interest accrue at an aggregate rate per year exceeding
0.50% of the principal amount of the Debentures and provided further that Additional Interest with
respect to such Transferred Restricted Securities shall not accrue under more than one of the
foregoing clauses (i), (ii) and (iii) at any one time. No Additional Interest shall be payable on
any Debentures that have been converted into shares of Common Stock or

 

7

such Common Stock, but Holders will receive on the next Payment Date Additional Interest accrued on the Debentures through
the date of conversion.

          (b) All accrued Additional Interest shall be paid in arrears to Record Holders by the Issuer
on each Additional Interest Payment Date by wire transfer of immediately available funds or by
federal funds check in accordance with the terms of the Indenture. Following the cure of all
Registration Defaults relating to any particular Debentures, the accrual of Additional Interest
with respect to such Debentures will cease. The Issuer agrees to deliver all notices, certificates
and other documents contemplated by the Indenture in connection with the payment of Additional
Interest.

          All obligations of the Issuer set forth in this Section 3 that are outstanding with respect to
any Transfer Restricted Security at the time such security ceases to be a Transfer Restricted
Security shall survive until such time as all such obligations with respect to such Transfer
Restricted Security shall have been satisfied in full. The Additional Interest set forth above
shall be the exclusive monetary remedy available to the Holders of Transfer Restricted Securities
for such Registration Default.

          4. Registration Procedures.

          (a) In connection with the registration of the Transfer Restricted Securities, the Issuer
shall comply with all the provisions of Section 4(b) hereof and shall use its reasonable best
efforts to effect such registration to permit the sale of the Transfer Restricted Securities being
sold in accordance with the intended method or methods of distribution thereof, and pursuant
thereto, shall as expeditiously as possible prepare and file with the Commission a Shelf
Registration Statement relating to the registration on any appropriate form under the Securities
Act.

          (b) In connection with the Shelf Registration Statement and any Prospectus required by this
Agreement to permit the sale or resale of Transfer Restricted Securities, the Issuer shall:

     (i) Subject to any notice by the Issuer in accordance with this Section 4(b)
of the existence of any fact or event of the kind described in Section
4(b)(iii)(D), use its reasonable best efforts to keep the Shelf Registration
Statement continuously effective during the Effectiveness Period; upon the
occurrence of any event that would cause the Shelf Registration Statement or the
Prospectus contained therein (A) to contain a material misstatement or omission or
(B) not be effective and usable for resale of Transfer Restricted Securities during
the Effectiveness Period, the Issuer shall file promptly an appropriate amendment
to the Shelf Registration Statement, a supplement to the Prospectus or a report
filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Exchange Act, in the case of clause (A), correcting any such misstatement or
omission, and, in the case of either clause (A) or (B), use its best efforts to
cause such amendment to be declared effective and the Shelf Registration Statement
and the related Prospectus to become usable for their intended purposes as soon as
practicable thereafter. Notwithstanding the

 

8

foregoing, the Issuer may suspend the effectiveness of the Shelf Registration Statement by written notice to the Holders
for a period not to exceed an aggregate of 45 days in any 90-day period (each such period, a “Suspension
Period”) and not to exceed an aggregate of 90 days in any 360-day period if:

     (x) an event occurs and is continuing as a result of which the Shelf
Registration Statement would, in the Issuer’s reasonable judgment, contain
an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein
not misleading; and

     (y) the Issuer reasonably determines that the disclosure of such
event at such time would have a material adverse effect on the business of
the Issuer (and its subsidiaries, if any, taken as a whole);

provided that in the event the disclosure relates to a previously undisclosed
proposed or pending material business transaction or agreement, the disclosure of
which would impede the Issuer’s ability to consummate such transaction or agreement,
the Issuer may extend a Suspension Period from 45 days to 60 days. Each Holder, by
its acceptance of the Debentures, agrees to hold any communication by us in
confidence.

     (ii) Subject to Section 4(b)(i), prepare and file with the Commission such
amendments and post-effective amendments to the Shelf Registration Statement as may
be necessary to keep the Shelf Registration Statement effective during the
Effectiveness Period; cause the Prospectus to be supplemented by any required
supplement, and as so supplemented to be filed pursuant to Rule 424 under the
Securities Act, and to comply fully with the applicable provisions of Rules 424 and
430A under the Securities Act in a timely manner; and comply with the provisions of
the Securities Act with respect to the disposition of all securities covered by the
Shelf Registration Statement during the applicable period in accordance with the
intended method or methods of distribution by the sellers thereof set forth in the
Shelf Registration Statement or supplement to the Prospectus; provided, that in no
event will such method(s) of distribution take the form of an Underwritten Offering
without the prior written agreement of the Issuer.

     (iii) Advise the underwriter(s), if any, and the selling Holders promptly (but
in any event within five Business Days) and, if requested by such Persons, to
confirm such advice in writing:

     (A) when the Prospectus or any supplement to the Prospectus or
post-effective amendment has been filed, and, with respect to the Shelf
Registration Statement or any post-effective amendment thereto, when the
same has become effective,

 

9

     (B) of any request by the Commission for amendments to the Shelf
Registration Statement or amendments or supplements to the Prospectus or for
additional information relating thereto,

     (C) of the issuance by the Commission of any stop order suspending the
effectiveness of the Shelf Registration Statement under the Securities Act
or of the suspension by any state securities commission of the qualification
of the Transfer Restricted Securities for offering or sale in any
jurisdiction, or the initiation of any proceeding for any of the preceding
purposes, or

     (D) of the existence of any fact or the happening of any event, during
the Effectiveness Period, that makes any statement of a material fact made
in the Shelf Registration Statement, the Prospectus, any amendment or
supplement thereto, or any document incorporated by reference therein
untrue, or that requires the making of any additions to or changes in the
Shelf Registration Statement or the Prospectus in order to make the
statements therein not misleading.

If at any time the Commission shall issue any stop order suspending the
effectiveness of the Shelf Registration Statement, or any state securities
commission or other regulatory authority shall issue an order suspending the
qualification or exemption from qualification of the Transfer Restricted Securities
under state securities or Blue Sky laws, the Issuer shall use its reasonable best
efforts to obtain the withdrawal or lifting of such order at the earliest possible
time and will provide to the Initial Purchasers and each Holder who is named in the
Shelf Registration Statement prompt notice of the withdrawal of any such order.

     (iv) Furnish to one counsel for the selling Holders designated by the Majority
of Holders whose Transfer Restricted Securities are included in a Shelf
Registration Statement, before filing with the Commission, a copy of the Shelf
Registration Statement and copies of any Prospectus included therein or any
amendments or supplements to the Shelf Registration Statement or Prospectus (other
than documents incorporated by reference after the initial filing of the Shelf
Registration Statement), which documents will be subject to the review of such
holders for a period of at least five Business Days (in the case of the Shelf
Registration Statement and Prospectus) and at least two Business Days (in the case
of any amendment or supplement thereto), and the Issuer will not file the Shelf
Registration Statement or Prospectus or any amendment or supplement to the Shelf
Registration Statement or Prospectus (other than documents incorporated by
reference) to which a selling Holder of Transfer Restricted Securities covered by
the Shelf Registration Statement shall reasonably object prior to the filing
thereof.

     (v) If requested by any selling Holders or the underwriter(s), if any,
promptly incorporate in the Shelf Registration Statement or Prospectus,

 

10

pursuant to a supplement or post-effective amendment if necessary, such information as such
selling Holders and underwriter(s), if any, may reasonably request to have included
therein, including, without limitation: (1) information relating to the “Plan of
Distribution” of the Transfer Restricted Securities, (2) information with respect to the principal amount of Debentures or number of
            shares of Common Stock being sold to such underwriter(s), (3) the purchase price
being paid therefor and (4) any other terms of the offering of the Transfer
Restricted Securities to be sold in such offering; and make all required filings of
such supplement or post-effective amendment as soon as reasonably practicable after
the Issuer is notified of the matters to be incorporated in such supplement or
post-effective amendment.

     (vi) Furnish to each selling Holder and each of the underwriter(s), if any,
upon their request, without charge, at least one copy of the Shelf Registration
Statement, as first filed with the Commission, and of each amendment thereto (and
any documents incorporated by reference therein or exhibits thereto (or exhibits
incorporated in such exhibits by reference) as such Person may request).

     (vii) Deliver to each selling Holder and each of the underwriter(s), if any,
without charge, as many copies of the Prospectus (including each preliminary
prospectus) and any amendment or supplement thereto as such Persons reasonably may
request; subject to any notice by the Issuer in accordance with this Section 4(b)
of the existence of any fact or event of the kind described in Section
4(b)(iii)(D), the Issuer hereby consents to the use (in accordance with applicable
law) of the Prospectus and any amendment or supplement thereto by each of the
selling Holders and each of the underwriter(s), if any, in connection with the
offering and the sale of the Transfer Restricted Securities covered by the
Prospectus or any amendment or supplement thereto.

     (viii) Before any public offering of Transfer Restricted Securities, cooperate
with the selling Holders, the underwriter(s), if any, and their respective counsel
in connection with the registration and qualification of the Transfer Restricted
Securities under the securities or Blue Sky laws of such jurisdictions in the
United States as the selling Holders or underwriter(s), if any, may reasonably
request and do any and all other acts or things necessary or advisable to enable
the disposition in such jurisdictions of the Transfer Restricted Securities covered
by the Shelf Registration Statement; provided, that the Issuer shall not be
required (A) to register or qualify as a foreign corporation or a dealer of
securities where it is not now so qualified or to take any action that would
subject it to the service of process in any jurisdiction where it is not now so
subject or (B) to subject itself to taxation in any such jurisdiction if it is not
now so subject.

     (ix) Cooperate with the selling Holders and the underwriter(s), if any, to
facilitate the timely preparation and delivery of certificates representing
Transfer Restricted Securities to be sold and not bearing any restrictive legends

 

11

(unless required by applicable securities laws); and enable such Transfer
Restricted Securities to be in such denominations and registered in such names as
the Holders or the underwriter(s), if any, may request at least two Business Days
before any sale of Transfer Restricted Securities made by such underwriter(s).

     (x) Subject to Section 4(b)(i) hereof, if any fact or event contemplated by
Section 4(b)(iii)(D) hereof shall exist or have occurred, use their reasonable best
efforts to prepare a supplement or post-effective amendment to the Shelf
Registration Statement or related Prospectus or any document incorporated therein
by reference or file any other required document so that, as thereafter delivered
to the purchasers of Transfer Restricted Securities, the Prospectus will not
contain an untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in light
of the circumstances in which they were made, not misleading.

     (xi) Provide CUSIP numbers for all Transfer Restricted Securities not later
than the effective date of the Shelf Registration Statement and provide the Trustee
under the Indenture with certificates for the Debentures that are in a form
eligible for deposit with The Depository Trust Company.

     (xii) Cooperate and assist in any filings required to be made with the NASD
and in the performance of any due diligence investigation by any underwriter that
is required to be retained in accordance with the rules and regulations of the
NASD.

     (xiii) Otherwise use their reasonable best efforts to comply with all
applicable rules and regulations of the Commission and all reporting requirements
under the Exchange Act.

     (xiv) Cause the Indenture to be qualified under the TIA not later than the
effective date of the Shelf Registration Statement required by this Agreement, and,
in connection therewith, cooperate with the Trustee and the holders of Debentures
to effect such changes to the Indenture as may be required for such Indenture to be
so qualified in accordance with the terms of the TIA; and execute and use their
reasonable best efforts to cause the Trustee thereunder to execute all documents
that may be required to effect such changes and all other forms and documents
required to be filed with the Commission to enable such Indenture to be so
qualified in a timely manner.

     (xv) Cause all Transfer Restricted Securities covered by the Shelf
Registration Statement to be listed or quoted, as the case may be, on each
securities exchange or automated quotation system on which similar securities
issued by the Issuer are then listed or quoted.

     (c) Each Holder agrees by acquisition of a Transfer Restricted Security that, upon receipt of
any notice (a “Suspension Notice”) from the Issuer of the existence of any fact of the kind
described in Section 4(b)(iii)(D) hereof, such Holder will, and will use their

 

12

reasonable best efforts to cause any underwriter(s) in an Underwritten Offering to, forthwith discontinue
disposition of Transfer Restricted Securities pursuant to the Shelf Registration Statement until:

     (i) such Holder has received copies of the supplemented or amended Prospectus
contemplated by Section 4(b)(xiii) hereof; or

     (ii) such Holder is advised in writing by the Issuer that the use of the
Prospectus may be resumed, and has received copies of any additional or
supplemental filings that are incorporated by reference in the Prospectus.

If so directed by the Issuer, each Holder will deliver to the Issuer (at the Issuer’s expense) all
copies, other than permanent file copies then in such Holder’s possession, of the Prospectus
covering such Transfer Restricted Securities that was current at the time of receipt of such notice
of suspension.

          5. Registration Expenses.

          (a) All expenses incident to the performance of or compliance with this Agreement by the
Issuer shall be borne by the Issuer regardless of whether a Shelf Registration Statement becomes
effective, including, without limitation:

     (i) all registration and filing fees and expenses (including filings made by
the Initial Purchasers or any Holders with the NASD);

     (ii) all fees and expenses of compliance with federal securities and state
Blue Sky or securities laws;

     (iii) all expenses of printing (including printing of Prospectuses and
certificates for the Common Stock to be issued upon conversion of the Debentures)
and the expenses of the Issuer for messenger and delivery services and telephone;

     (iv) all fees and disbursements of counsel to the Issuer;

     (v) all application and filing fees in connection with listing (or authorizing
for quotation) the Common Stock on a national securities exchange or automated
quotation system pursuant to the requirements hereof; and

     (vi) all fees and disbursements of independent certified public accountants of
the Issuer (including the expenses of any special audit and comfort letters
required by or incident to such performance).

          The Issuer shall bear their internal expenses (including, without limitation, all salaries and
expenses of their officers and employees performing legal, accounting or other duties), the
expenses of any annual audit and the fees and expenses of any Person, including special experts,
retained by the Issuer.

 

13

          (b) The Issuer shall not be required to pay any underwriting discount, commission or
similar fee related to the sale of any securities.

          6. Indemnification and Contribution.

          (a) The Issuer shall indemnify and hold harmless each Holder, its officers, directors,
partners and employees and each person, if any, who controls any such Holder within the meaning of
the Securities Act (each, an “Indemnified Holder”), from and against any loss, claim, damage or
liability, or any action in respect thereof (including, but not limited to, any loss, claim,
damage, liability or action relating to resales of the Transfer Restricted Securities), to which
such Indemnified Holder may become subject, insofar as any such loss, claim, damage, liability or
action arises out of, or is based upon (i) any untrue statement or alleged untrue statement of a
material fact contained in the Shelf Registration Statement or Prospectus or any amendment or
supplement thereto or (ii) the omission or alleged omission to state therein any material fact
required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, and shall reimburse each Indemnified
Holder promptly upon demand for any legal or other expenses reasonably incurred by such Indemnified
Holder in connection with investigating or defending or preparing to defend against any such loss,
claim, damage, liability or action as such expenses are incurred; provided, that the Issuer shall
not be liable in any such case to the extent that any such loss, claim, damage, liability or action
arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or
alleged omission made in the Shelf Registration Statement or Prospectus or amendment or supplement
thereto in reliance upon and in conformity with written information furnished to the Issuer by or
on behalf of such Holder; provided, further, that the Issuer shall not be liable for any loss,
claim, damage, liability or expense to the extent that it arises from a sale of Transfer Restricted
Securities occurring during a Suspension Period, provided that the Issuer shall have given a
Suspension Notice in accordance with this Agreement with respect to such Suspension Period prior to
such sale. The foregoing indemnity agreement is in addition to any liability which the Issuer may
otherwise have to any Indemnified Holder.

          (b) Each Holder, severally and not jointly, shall indemnify and hold harmless the Issuer, its
officers, directors and employees and each person, if any, who controls the Issuer within the
meaning of the Securities Act, from and against any loss, claim, damage or liability, or any action
in respect thereof, to which the Issuer, or any such officer, director, employee or controlling
person may become subject, insofar as any such loss, claim, damage or liability or action arises
out of, or is based upon (i) any untrue statement or alleged untrue statement of any material fact
contained in the Shelf Registration Statement or Prospectus or any amendment or supplement thereto
or (ii) the omission or the alleged omission to state therein any material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, but in each case only to the extent that such untrue
statement or alleged untrue statement or omission or alleged omission was made in reliance upon and
in conformity with written information furnished to the Issuer by or on behalf of such Holder (or
its related Indemnified Holder) specifically for use therein, and shall reimburse the Issuer and
any such officer, director, employee or controlling person promptly upon demand for any legal or
other expenses reasonably incurred by the Issuer or any such officer, director, employee or
controlling person in connection with investigating or defending or preparing to defend against any
such loss, claim, damage, liability or action as such expenses are

 

14

incurred. The foregoing indemnity agreement is in addition to any liability that any Holder
may otherwise have to the Issuer and any such officer, employee or controlling person.

          (c) Promptly after receipt by an indemnified party under this Section 6 of notice of any claim
or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to
be made against the indemnifying party under this Section 6, notify the indemnifying party in
writing of the claim or the commencement of that action; provided, that the failure to notify the
indemnifying party shall not relieve it from any liability which it may have under this Section 6
except to the extent it has been materially prejudiced by such failure and, provided, further, that
the failure to notify the indemnifying party shall not relieve it from any liability which it may
have to an indemnified party otherwise than under this Section 6. If any such claim or action
shall be brought against an indemnified party, and it shall notify the indemnifying party thereof,
the indemnifying party shall be entitled to participate therein and, to the extent that it wishes,
jointly with any other similarly notified indemnifying party, to assume the defense thereof with
counsel satisfactory to the indemnified party. After notice from the indemnifying party to the
indemnified party of its election to assume the defense of such claim or action, the indemnifying
party shall not be liable to the indemnified party under this Section 6 for any legal or other
expenses subsequently incurred by the indemnified party in connection with the defense thereof
other than reasonable costs of investigation; provided, that a Majority of Holders shall have the
right to employ a single counsel to represent jointly a Majority of Holders and their respective
officers, directors, partners, employees and controlling persons who may be subject to liability
arising out of any claim in respect of which indemnity may be sought by a Majority of Holders
against the Issuer under this Section 6, if a Majority of Holders seeking indemnification shall
have been advised by legal counsel that there may be one or more legal defenses available to them
and their respective officers, employees and controlling persons that are different from or
additional to those available to the Issuer and its officers, directors, employees and controlling
persons, the fees and expenses of a single separate counsel shall be paid by the Issuer. No
indemnifying party shall:

     (i) without the prior written consent of the indemnified parties (which consent shall
not be unreasonably withheld) settle or compromise or consent to the entry of any judgment
with respect to any pending or threatened claim, action, suit or proceeding in respect of
which indemnification or contribution may be sought hereunder (whether or not the
indemnified parties are actual or potential parties to such claim or action) unless such
settlement, compromise or consent includes an unconditional release of each indemnified
party from all liability arising out of such claim, action, suit or proceeding, or

     (ii) be liable for any settlement of any such action effected without its written
consent (which consent shall not be unreasonably withheld), but if settled with its written
consent or if there be a final judgment for the plaintiff in any such action, the
indemnifying party agrees to indemnify and hold harmless any indemnified party from and
against any loss or liability by reason of such settlement or judgment.

          (d) If the indemnification provided for in this Section 6 shall for any reason be unavailable
or insufficient to hold harmless an indemnified party under Section 6(a) or 6(b) in respect of any
loss, claim, damage or liability (or action in respect thereof) referred to therein,

 

15

each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to
the amount paid or payable by such indemnified party as a result of such loss, claim, damage or
liability (or action in respect thereof) in such proportion as the relative fault of the Issuer on
the one hand and the Holders on the other in connection with the statements or omissions or alleged
statements or alleged omissions that resulted in such loss, claim, damage or liability (or action
in respect thereof), as well as any other relevant equitable considerations.

The relative benefits received by a Holder shall be equal to the value of receiving registration
rights under this Agreement for the Transfer Restricted Securities. The relative fault of the
parties shall be determined by reference to whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Issuer on the one hand or the Holders on the other, the intent of the parties and
their relative knowledge, access to information and opportunity to correct or prevent such
statement or omission. The Issuer and each Holder agree that it would not be just and equitable if
the amount of contribution pursuant to this Section 6(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations
referred to in the first sentence of this paragraph (d). The amount paid or payable by an
indemnified party as a result of the loss, claim, damage or liability, or action in respect
thereof, referred to above in this Section 6 shall be deemed to include, for purposes of this
Section 6, any legal or other expenses reasonably incurred by such indemnified party in connection
with investigating or defending or preparing to defend any such action or claim. Notwithstanding
the provisions of this Section 6, no Holder shall be required to contribute any amount in excess of
the amount by which the total price at which the Transfer Restricted Securities purchased by it
were resold exceeds the amount of any damages which such Holder has otherwise been required to pay
by reason of any untrue or alleged untrue statement or omission or alleged omission. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Holders’ obligations to contribute as provided in this Section 6(d) are
several and not joint.

          7. Rule 144A. In the event the Issuer is not subject to Section 13 or 15(d) of the Exchange Act,
the Issuer hereby agrees with each Holder, for so long as any Transfer Restricted Securities remain
outstanding, to make available to any Holder or beneficial owner of Transfer Restricted Securities
in connection with any sale thereof and any prospective purchaser of such Transfer Restricted
Securities from such Holder or beneficial owner, the information required by Rule 144A(d)(4) under
the Securities Act in order to permit resales of such Transfer Restricted Securities pursuant to
Rule 144A.

          8. Participation in Underwritten Registrations. No Holder may participate in any Underwritten
Registration hereunder unless such Holder:

     (i) agrees to sell such Holder’s Transfer Restricted Securities on the basis provided
in any underwriting arrangements approved by the Persons entitled hereunder to approve such
arrangements; and

 

16

     (ii) completes and executes all reasonable questionnaires, powers of attorney,
indemnities, underwriting agreements, lock-up letters and other documents required under the
terms of such underwriting arrangements.

          9. Selection of Underwriters. The Holders of Transfer Restricted Securities covered by the Shelf
Registration Statement who desire to do so may sell such Transfer Restricted Securities in an
Underwritten Offering if approved by the Issuer, as provided in Section 4(b)(ii). In any such
Underwritten Offering, the investment banker or investment bankers and manager or managers that
will administer the offering will be selected by a Majority of Holders whose Transfer Restricted
Securities are included in such offering; provided, that such investment bankers and managers must
be reasonably satisfactory to the Issuer.

          10. Miscellaneous.

          (a) Remedies. The Issuer acknowledge and agree that any failure by the Issuer to comply with
its obligations under Section 2 hereof may result in material irreparable injury to the Initial
Purchasers or the Holders for which there is no adequate remedy at law, that it will not be
possible to measure damages for such injuries precisely and that, in the event of any such failure,
the Initial Purchasers or any Holder may obtain such relief as may be required to specifically
enforce the obligations of the Issuer under Section 2 hereof. The Issuer further agrees to waive
the defense in any action for specific performance that a remedy at law would be adequate.

          (b) Adjustments Affecting Transfer Restricted Securities. The Issuer shall not take any
action with the primary purpose of adversely affecting the ability of the Holders of the Transfer
Restricted Securities as a class to include such Transfer Restricted Securities in a registration
undertaken pursuant to this Agreement.

          (c) No Inconsistent Agreements. The Issuer will not, on or after the date of this Agreement,
enter into any agreement with respect to its securities that is inconsistent with the rights
granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except
as disclosed in the Offering Memorandum, the Issuer has not previously entered into any agreement
(which has not expired or been terminated) granting any registration rights with respect to its
securities to any Person which rights conflict with the provisions hereof.

          (d) Amendments and Waivers. Except as provided in the next paragraph, this Agreement may not
be amended, modified or supplemented, and waivers or consents to or departures from the provisions
hereof may not be given, unless the Issuer has obtained the written consent of a Majority of
Holders or such greater percentage of the Holders as required by the Indenture.

     In the event of a merger or consolidation or sale, assignment, conveyance, transfer, lease or
other disposition of all or substantially all of the properties and assets of the Issuer and its
subsidiaries on a consolidated basis, the Issuer shall procure the assumption of its obligations
under this Agreement (which it is understood and agreed shall include the registration of any other
securities into which the Debentures or the Common Stock that are Transfer Restricted Securities
(the “New Securities”) have become convertible on substantially the same terms as

 

17

provided for the registration of the Common Stock) by the Person (if other than the Issuer) formed by such
consolidation or into which the Issuer is merged or the Person who acquires by sale, assignment,
conveyance, transfer, lease or other disposition all or substantially all of the properties and
assets of the Issuer and its subsidiaries on a consolidated basis and this Agreement may be
amended, modified or supplemented without the consent of any Holders to provide for such assumption
of the Issuer’s obligations hereunder (including the registration of any New Securities). Without
the consent of each Holder of Debentures, no amendment or modification may change the provisions
relating to the payment of Additional Interest during the pendency of a Registration Default.

     Each Holder of Transfer Restricted Securities outstanding at the time of any amendment,
modification, supplement, waiver or consent or thereafter shall be bound by any amendment,
modification, supplement, waiver or consent effected pursuant to this Section 10(d), whether or not
any notice, writing or marking indicating such amendment, modification, supplement, waiver or
consent appears on the Transfer Restricted Securities or is delivered to such Holder.

          (e) Notices. All notices and other communications provided for or permitted hereunder shall
be made in writing by hand-delivery, first-class mail (registered or certified, return receipt
requested), telex, facsimile transmission, or air courier guaranteeing overnight delivery:

     (i) if to a Holder, at the address set forth on the records of the registrar
under the Indenture or the transfer agent of the Common Stock, as the case may be;
and

     (ii) if to the Issuer:

Global Industries Ltd.

800 Global Drive

Carlyss, Louisiana 70665

Attention: General Counsel

Telephone: (281) 529-7740

Facsimile: (281) 529-7747

With a copy to:

Vinson & Elkins L.L.P.

2300 First City Tower

1001 Fannin Street

Houston, TX 77002-6760

Attention: Jeff Floyd

Telephone: (713) 758-2222

Facsimile: (713) 758-2346

          All such notices and communications shall be deemed to have been duly given: at the time
delivered by hand, if personally delivered; five Business Days after being deposited in the mail,
postage prepaid, if mailed; when answered back, if telexed; when receipt

 

18

acknowledged, if transmitted by facsimile; and on the next Business Day, if timely delivered to an air courier
guaranteeing overnight delivery.

          (f) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon
the successors and assigns of each of the parties, including without limitation and without the
need for an express assignment, subsequent Holders of Transfer Restricted Securities; provided,
that (i) this Agreement shall not inure to the benefit of or be binding upon a successor or assign
of a Holder unless and to the extent such successor or assign acquired Transfer Restricted
Securities from such Holder and (ii) nothing contained herein shall be deemed to permit any
assignment, transfer or other disposition of Transfer Restricted Securities in violation of the
terms of the Purchase Agreement or the Indenture. If any transferee of any Holder shall acquire
Transfer Restricted Securities, in any manner, whether by operation of law or otherwise, such
Transfer Restricted Securities shall be held subject to all of the terms of this Agreement, and by
taking and holding such Transfer Restricted Securities such person shall be conclusively deemed to
have agreed to be bound by and to perform all of the terms and provisions of this Agreement.

          (g) Counterparts. This Agreement may be executed in any number of counterparts and by the
parties hereto in separate counterparts, each of which when so executed shall be deemed to be an
original and all of which taken together shall constitute one and the same agreement.

          (h) Debentures Held by the Issuer or Its Affiliates. Whenever the consent or approval of
Holders of a specified percentage of Transfer Restricted Securities is required hereunder, Transfer
Restricted Securities held by the Issuer or its “affiliates” (as such term is defined in Rule 405
under the Securities Act) shall not be counted in determining whether such consent or approval was
given by the Holders of such required percentage.

          (i) Headings. The headings in this Agreement are for convenience of reference only and shall
not limit or otherwise affect the meaning hereof.

          (j) Governing Law. This Agreement shall be governed by, and construed in accordance with, the
law of the State of New York.

          (k) Severability. If any one or more of the provisions contained herein, or the application
thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and
enforceability of any such provision in every other respect and of the remaining provisions
contained herein shall not be affected or impaired thereby.

          (l) Entire Agreement. This Agreement is intended by the parties as a final expression of
their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained
herein. There are no restrictions, promises, warranties or undertakings, other than those set
forth or referred to herein with respect to the registration rights granted by the Issuer with
respect to the Transfer Restricted Securities. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter.

 

19

          (m) Termination. This Agreement and the obligations of the parties hereunder shall terminate
when there are no longer any Transfer Restricted Securities outstanding, except for any liabilities
or obligations under Sections 5, 6 or 10 hereof, each of which shall remain in effect in accordance
with its terms.

 

20

          In Witness Whereof, the parties have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	 	Global Industries, Ltd. 

 	 
	 	By  	/s/ Peter S. Atkinson
 	 
	 	 	Name:  	Peter S. Atkinson 	 
	 	 	Title:  	President and Chief Financial Officer 	 
	 
	 	Lehman Brothers Inc.

For itself and as Representative of the other

Initial Purchasers

 	 
	 	By:  

 	Lehman Brothers Inc. 

 	
 	 
	 	 	 
	 	By:  	                                              /s/ Arlene Salmonson
 	 
	 	 	Name:  	Arlene Salmonson 	 
	 	 	Title:  	Vice Presidentexv10w1

 

EXHIBIT 10.1

EXECUTION
COPY

$325,000,000

GLOBAL INDUSTRIES, LTD.

2.75% Senior Convertible Debentures due 2027

PURCHASE AGREEMENT

July 23, 2007

Lehman Brothers Inc., 

As Representative of the several

   Initial Purchasers named in Schedule I attached hereto,

c/o Lehman Brothers Inc.

745 Seventh Avenue

New York, New York 10019

Ladies and Gentlemen:

     Global Industries, Ltd., a Louisiana corporation (the “Company”), proposes, upon the terms and
conditions set forth in this agreement (this “Agreement”), to issue and sell to you, as the initial
purchasers (the “Initial Purchasers”), $325,000,000 in aggregate principal amount of its 2.75%
Senior Convertible Debentures due 2027 (the “Firm Securities”). The Firm Securities will (i) have
terms and provisions that are summarized in the Pricing Disclosure Package (as defined below) and
Offering Memorandum (as defined below) and (ii) are to be issued pursuant to an Indenture (the
“Indenture”) to be entered into between the Company and Wells Fargo Bank, N.A., as trustee (the
“Trustee”). The Company also proposes to issue and sell to the Initial Purchasers not more than an
additional $50,000,000 principal amount of its 2.75% Senior Convertible Debentures due 2027 (the
“Additional Securities”) if and to the extent that you, as Representative of the Initial
Purchasers, shall have determined to exercise, on behalf of the Initial Purchasers, the right to
purchase such 2.75% Senior Convertible Debentures due 2027 granted to the Initial Purchasers in
Section 3(a) hereof. The Firm Securities and the Additional Securities are hereinafter
collectively referred to as the “Securities”. The Securities will be convertible into shares (the
“Underlying Securities”) of the Company’s common stock, par value $0.01 per share (the “Common
Stock”). This is to confirm the agreement concerning the purchase of the Securities from the
Company by the Initial Purchasers.

     1. Purchase and Resale of the Securities. The Securities will be offered and sold to the
Initial Purchasers without registration under the Securities Act of 1933, as amended (the
“Securities Act”), in reliance on an exemption from the Securities Act. The Company has prepared
a preliminary offering memorandum, dated July 23, 2007 (the “Preliminary Offering Memorandum”), a
pricing term sheet substantially in the form attached hereto as Schedule II (the “Pricing Term
Sheet”) setting forth the terms of the Securities omitted from the Preliminary Offering Memorandum
and an offering memorandum, dated July 23, 2007 (the “Offering Memorandum”), setting forth
information regarding the Company and the Securities. The Preliminary Offering Memorandum, as
supplemented and amended as of the Applicable

 

 

Time (as defined below), together with the Pricing Term Sheet and any of the documents listed
on Schedule III hereto are collectively referred to as the “Pricing Disclosure Package.” The
Company hereby confirms that it has authorized the use of the Preliminary Offering Memorandum, the
Pricing Disclosure Package and the Offering Memorandum in connection with the offering and resale
of the Securities by the Initial Purchasers. “Applicable Time” means 4:00 p.m. (New York City time)
on the date of this Agreement.

     Any reference to the Preliminary Offering Memorandum or the Offering Memorandum shall be
deemed to refer to and include the Company’s most recent Annual Report on Form 10-K and all
subsequent documents filed with the United States Securities and Exchange Commission (the
“Commission”) pursuant to Section 13(a) or 15(d) of the United States Securities Exchange Act of
1934, as amended (the “Exchange Act”), on or prior to the date of the Preliminary Offering
Memorandum or the Offering Memorandum, as the case may be. Any reference to the Preliminary
Offering Memorandum or the Offering Memorandum, as the case may be, as amended or supplemented, as
of any specified date, shall be deemed to include (i) any documents filed with the Commission
pursuant to Section 13(a) or 15(d) of the Exchange Act after the date of the Preliminary Offering
Memorandum or the Offering Memorandum, as the case may be, and prior to such specified date. All
documents filed under Section 13(a) or 15(d) of the Exchange Act and so deemed to be included in
the Preliminary Offering Memorandum or the Offering Memorandum, as the case may be, or any
amendment or supplement thereto are hereinafter called the “Exchange Act Reports.” The Exchange
Act Reports, when they were or are filed with the Commission, conformed or will conform in all
material respects to the applicable requirements of the Exchange Act and the applicable rules and
regulations of the Commission thereunder.

     It is understood and acknowledged that upon original issuance thereof, and until such time as
the same is no longer required under the applicable requirements of the Securities Act, the
Securities (and all securities issued in exchange therefor or in substitution thereof) shall bear
the following legend (along with such other legends as the Initial Purchasers and their counsel
deem necessary):

“THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”). NEITHER THIS SECURITY NOR ANY INTEREST
OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED,
ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS
THE TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT. EACH PURCHASER OF THE SECURITY EVIDENCED HEREBY IS NOTIFIED THAT
THE SELLER MAY BE RELYING ON THE EXEMPTION FROM SECTION 5 OF THE SECURITIES ACT
PROVIDED BY RULE 144A THEREUNDER. THE HOLDER OF THIS SECURITY BY ITS ACCEPTANCE
HEREOF (1) REPRESENTS THAT IT IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN
RULE 144A UNDER THE SECURITIES ACT), (2) AGREES THAT IT WILL NOT PRIOR TO (X) THE
DATE WHICH IS TWO YEARS (OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY

2

 

RULE 144(K) UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THEREUNDER) AFTER
THE LATER OF THE ORIGINAL ISSUE DATE HEREOF (OR OF ANY PREDECESSOR OF THIS SECURITY)
OR THE LAST DAY ON WHICH THE COMPANY OR ANY AFFILIATE OF THE COMPANY WAS THE OWNER
OF THIS SECURITY (OR ANY PREDECESSOR OF THIS SECURITY) AND (Y) SUCH LATER DATE, IF
ANY, AS MAY BE REQUIRED BY APPLICABLE LAW (THE “RESALE RESTRICTION TERMINATION
DATE”), OFFER, SELL OR OTHERWISE TRANSFER THIS SECURITY EXCEPT (A) TO THE COMPANY,
(B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE
SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT
TO RULE 144A, TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL
BUYER” AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT THAT PURCHASES FOR ITS OWN
ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS
GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A OR (D) PURSUANT TO
ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND (3) AGREES THAT IT WILL GIVE TO EACH PERSON TO WHOM THIS SECURITY IS
TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND; PROVIDED THAT THE
COMPANY, THE TRUSTEE AND THE REGISTRAR SHALL HAVE THE RIGHT PRIOR TO ANY SUCH OFFER,
SALE OR TRANSFER PURSUANT TO CLAUSE (D) TO REQUIRE THE DELIVERY OF AN OPINION OF
COUNSEL, CERTIFICATION AND/OR OTHER INFORMATION SATISFACTORY TO EACH OF THEM. THIS
LEGEND WILL BE REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE RESALE RESTRICTION
TERMINATION DATE.”

     You have advised the Company that you will make offers (the “Exempt Resales”) of the
Securities purchased by you hereunder on the terms set forth in each of the Pricing Disclosure
Package and the Offering Memorandum, as amended or supplemented, solely to persons (the “Eligible
Purchasers”) whom you reasonably believe to be “qualified institutional buyers” as defined in Rule
144A under the Securities Act (“QIBs”). You will offer the Securities to Eligible Purchasers
initially at a price equal to 100% of the principal amount thereof plus accrued interest, if any.
Such price may be changed at any time without notice.

     Holders (including subsequent transferees) of the Securities will have the registration rights
set forth in a registration rights agreement substantially in the form attached hereto as Exhibit A
and in accordance with the terms set forth in the Preliminary Offering Memorandum (the
“Registration Rights Agreement”) between the Company and the Initial Purchasers to be dated July
27, 2007 (the “Closing Date”), for so long as such Securities constitute “Transfer Restricted
Securities” (as defined in the Registration Rights Agreement). Pursuant to the Registration Rights
Agreement, the Company will agree to file with the Commission under the circumstances set forth
therein, a shelf registration statement under the Securities Act (the

3

 

“Resale Registration Statement”) relating to resales by holders of the Securities and the
Underlying Securities.

     2. Representations, Warranties and Agreements of the Company. The Company represents,
warrants and agrees as follows:

          (a) When the Securities are issued and delivered pursuant to this Agreement, the Securities
will satisfy the requirements set forth in Rule 144A(d)(3).

          (b) Neither the Company nor any subsidiary is, and after giving effect to the offer and sale
of the Securities and the application of the proceeds therefrom as described under “Use of
Proceeds” in each of the Pricing Disclosure Package and the Offering Memorandum will be, an
“investment company” as such term is defined in the Investment Company Act of, as amended, and the
rules and regulations of the Commission thereunder.

          (c) Assuming that your representations and warranties in Section 3(b) are true, the purchase
and resale of the Securities pursuant hereto (including pursuant to the Exempt Resales) is exempt
from the registration requirements of the Securities Act. No form of general solicitation or
general advertising within the meaning of Regulation D was used by the Company or any of its
representatives (other than you, as to whom the Company makes no representation) in connection with
the offer and sale of the Securities.

          (d) Each of the Preliminary Offering Memorandum and the Offering Memorandum, each as of its
respective date, contains all the information specified in, and meeting the requirements of, Rule
144A(d)(4) under the Securities Act.

          (e) No order or decree preventing the use of the Preliminary Offering Memorandum, the Pricing
Disclosure Package or the Offering Memorandum, or any order asserting that the transactions
contemplated by this Agreement are subject to the registration requirements of the Securities Act
has been issued, and no proceeding for that purpose has commenced or is pending or, to the
knowledge of the Company, is contemplated.

          (f) The Pricing Disclosure Package did not, as of the Applicable Time, and will not, as of the
Closing Date, contain an untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements made therein, in the light of the circumstances under
which they were made, not misleading; provided that no representation or warranty is made as to
information contained in or omitted from the Pricing Disclosure Package in reliance upon and in
conformity with written information furnished to the Company through the Representative by or on
behalf of any Initial Purchaser specifically for inclusion therein, which information is specified
in Section 8(e).

          (g) The Offering Memorandum will not, as of its date and as of the Closing Date, contain an
untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not
misleading; provided that no representation or warranty is made as to information contained in or
omitted from the Offering Memorandum in reliance upon and in conformity with written information
furnished to the Company through the Representative by or

4

 

on behalf of any Initial Purchaser specifically for inclusion therein, which information is
specified in Section 8(e).

          (h) The Company has not made any offer to sell or solicitation of an offer to buy the
Securities that would constitute a “free writing prospectus” (if the offering of the Securities was
made pursuant to a registered offering under the Securities Act), as defined in Rule 405 under the
Securities Act (a “Free Writing Offering Document”) without the prior consent of the
Representative; any such Free Writing Offering Document the use of which has been previously
consented to by the Initial Purchasers is set forth substantially in form and substance as attached
hereto on Schedule III.

          (i) The Exchange Act Reports did not, when filed with the Commission, contain an untrue
statement of material fact or omit to state a material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not
misleading.

          (j) Each of the Company and its subsidiaries has been duly organized and is validly existing
and in good standing as a corporation or other business entity under the laws of its jurisdiction
of organization and is duly qualified to do business and in good standing as a foreign corporation
or other business entity in each jurisdiction in which its ownership or lease of property or the
conduct of its businesses requires such qualification, except where the failure to be so qualified
or in good standing would not, in the aggregate, reasonably be expected to have a material adverse
effect on the condition (financial or otherwise), results of operations, properties or business of
the Company and its subsidiaries taken as a whole or a material adverse effect on the performance
by the Company of this Agreement, the Indenture, the Securities or the Registration Rights
Agreement or the consummation of any of the transactions contemplated hereby or thereby (a
“Material Adverse Effect”); each of the Company and its subsidiaries has all power and authority
necessary to own or hold its properties and to conduct the businesses described in the Offering
Memorandum. The subsidiaries listed in Exhibit 21.1 to the Company’s Annual Report on Form 10-K
for the fiscal year ended December 31, 2006 are the only “subsidiaries” (as defined in Rule 405
under the Securities Act) of the Company (excluding those subsidiaries that may be omitted from
such list pursuant to Form 10-K).

          (k) The Company has an authorized capitalization as set forth in each of the Pricing
Disclosure Package and the Offering Memorandum, and all of the issued shares of capital stock of
the Company have been duly authorized and validly issued and are fully paid and non-assessable; and
all of the issued shares of capital stock of each subsidiary of the Company have been duly
authorized and validly issued, are fully paid and non-assessable and (except for directors’
qualifying shares for foreign subsidiaries and except as set forth in each of the Pricing
Disclosure Package and the Offering Memorandum) are owned directly or indirectly by the Company,
free and clear of all liens, encumbrances, equities or claims, except for such liens, encumbrances,
equities or claims as would not, in the aggregate, reasonably be expected to have a Material
Adverse Effect.

          (l) The Company has all requisite corporate power and authority to execute, deliver and
perform its obligations under the Indenture. The Indenture has been duly and validly authorized by
the Company, and upon its execution and delivery and, assuming due

5

 

authorization, execution and delivery by the Trustee, will constitute the valid and binding
agreement of the Company, enforceable against the Company in accordance with its terms, except as
such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency,
reorganization, moratorium, and other laws relating to or affecting creditors’ rights generally and
by general equitable principles (regardless of whether such enforceability is considered in a
proceeding in equity or at law); no qualification of the Indenture under the Trust Indenture Act of
1939 (the “1939 Act”) is required in connection with the offer and sale of the Securities in the
manner contemplated hereby. The Indenture will conform to the description thereof in each of the
Pricing Disclosure Package and the Offering Memorandum.

          (m) The Company has all requisite corporate power and authority to execute, issue, sell and
perform its obligations under the Securities. The Securities have been duly authorized by the
Company and, when duly executed by the Company in accordance with the terms of the Indenture,
assuming due authentication of the Securities by the Trustee, upon delivery to the Initial
Purchasers against payment therefor in accordance with the terms hereof, will be validly issued and
delivered and will constitute valid and binding obligations of the Company entitled to the benefits
of the Indenture, enforceable against the Company in accordance with their terms, except as such
enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization,
moratorium, and other laws relating to or affecting creditors’ rights generally and by general
equitable principles (regardless of whether such enforceability is considered in a proceeding in
equity or at law). The Securities will conform in all material respects to the description thereof
in each of the Pricing Disclosure Package and the Offering Memorandum.

          (n) The Company has all the requisite corporate power and authority to issue the Underlying
Securities issuable upon conversion of the Securities. The Underlying Securities have been duly
and validly authorized by the Company and, and when issued upon conversion of the Securities in
accordance with the terms of the Securities, will be validly issued, fully paid and non-assessable,
and the issuance of the Underlying Securities will not be subject to any preemptive or similar
rights.

          (o) The Company has all requisite corporate power and authority to execute, deliver and
perform its obligations under the Registration Rights Agreement. The Registration Rights Agreement
has been duly authorized by the Company and, when executed and delivered by the Company in
accordance with the terms hereof and thereof, will be validly executed and delivered and (assuming
the due authorization, execution and delivery thereof by you) will constitute valid and binding
obligations of the Company, enforceable against the Company in accordance with its terms, except as
such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other
similar laws relating to or affecting creditor’s rights generally, by general equitable principles
(regardless of whether such enforceability is considered in a proceeding in equity or at law) and,
as to rights of indemnification and contribution, by principles of public policy. The Registration
Rights Agreement will conform to the description thereof in each of the Pricing Disclosure Package
and the Offering Memorandum.

          (p) The Company has all requisite corporate power to execute, deliver and perform its
obligations under this Agreement. This Agreement has been duly authorized and validly executed and
delivered by the Company.

6

 

          (q) The issue and sale of the Securities, the execution, delivery and performance by the
Company of the Securities, the Indenture, the Registration Rights Agreement and this Agreement, the
application of the proceeds from the sale of the Securities as described under “Use of Proceeds” in
each of the Pricing Disclosure Package and the Offering Memorandum and the consummation of the
transactions contemplated hereby and thereby, will not (i) conflict with or result in a breach or
violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any
property or assets of the Company or its subsidiaries, or constitute a default under, any
indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of the Company or any of its
subsidiaries is subject, (ii) result in any violation of the provisions of the charter or by-laws
or similar organizational document of the Company or any of its subsidiaries or (iii) result in any
violation of any statute or any judgment, order, decree, rule or regulation of any court or
governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any
of their properties or assets, except, with respect to clauses (i) and (iii), conflicts or
violations that would not reasonably be expected to have a Material Adverse Effect.

          (r) No consent, approval, authorization or order of, or filing, registration or qualification
with any court or governmental agency or body having jurisdiction over the Company or any of its
subsidiaries is required for the issue and sale of the Securities, the execution, delivery and
performance by the Company of the Securities, the Indenture, the Registration Rights Agreement and
this Agreement, the application of the proceeds from the sale of the Securities as described under
“Use of Proceeds” in each of the Pricing Disclosure Package and the Offering Memorandum and the
consummation of the transactions contemplated hereby and thereby, except for (A) the filing of a
registration statement by the Company with the Commission pursuant to the Securities Act as
required by the Registration Rights Agreement, (B) such consents, approvals, authorizations,
orders, filings, registrations or qualifications as may be required under state securities or Blue
Sky laws in connection with the purchase and distribution of the Securities by the Initial
Purchasers and (C) such consents the failure to obtain would not have a Material Adverse Effect.

          (s) Except as identified in the Pricing Disclosure Package and the Offering Memorandum, there
are no contracts, agreements or understandings between the Company and any person granting such
person the right to require the Company to file a registration statement under the Securities Act
with respect to any securities of the Company (other than the Registration Rights Agreement) owned
or to be owned by such person or to require the Company to include such securities in the
securities registered pursuant to the Registration Rights Agreement or in any securities being
registered pursuant to any other registration statement filed by the Company under the Securities
Act except as set forth in the Non-Competition and Registration Rights Agreement filed as Exhibit
10.7 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2002.

          (t) Neither the Company nor any other person acting on behalf of the Company has sold or
issued any securities that would be integrated with the offering of the Securities contemplated by
this Agreement pursuant to the Securities Act, the rules and regulations thereunder or the
interpretations thereof by the Commission. The Company will take

7

 

reasonable precautions designed to insure that any offer or sale, direct or indirect, in the
United States or to any U.S. person (as defined in Rule 902 under the Securities Act), of any
Securities or any substantially similar security issued by the Company, within six months
subsequent to the date on which the distribution of the Securities has been completed (as notified
to the Company by the Initial Purchasers), is made under restrictions and other circumstances
reasonably designed not to affect the status of the offer and sale of the Securities in the United
States and to U.S. persons contemplated by this Agreement as transactions exempt from the
registration provisions of the Securities Act, including any sales pursuant to Rule 144A under the
Securities Act.

          (u) Except as described in the each of the Pricing Disclosure Package and the Offering
Memorandum, neither the Company nor any of its subsidiaries has sustained, since the date of the
latest audited financial statements included in the Pricing Disclosure Package, any loss or
interference with its business from fire, explosion, flood or other calamity, whether or not
covered by insurance, or from any labor dispute or court or governmental action, order or decree,
and, since such date, there has not been any change in the capital stock or long-term debt of the
Company or any of its subsidiaries or any adverse change, or any development involving a
prospective adverse change that has had or would have a Material Adverse Effect.

          (v) The historical financial statements (including the related notes and supporting schedules)
included in the Pricing Disclosure Package and the Offering Memorandum present fairly in all
material respects the financial condition, results of operations and cash flows of the entities
purported to be shown thereby, at the dates and for the periods indicated, and have been prepared
in conformity with accounting principles generally accepted in the United States applied on a
consistent basis throughout the periods involved. The other financial information and data
included in the Offering Memorandum are, in all material respects, accurately presented and
prepared on a basis consistent with such financial statements and the books and records of the
Company.

          (w) Deloitte & Touche LLP, who have certified certain financial statements of the Company,
whose report appears in the Pricing Disclosure Package, are independent public accountants as
required by the Securities Act and the rules and regulations thereunder.

          (x) The Company and its significant subsidiaries have good and marketable title to, or valid
and enforceable leasehold interests in, all of their owned and leased real properties and good and
marketable title to, or valid and enforceable leasehold interests in, all other material properties
owned or leased by them, in each case, free and clear of all mortgages, pledges, liens, security
interests, claims, restrictions or encumbrances of any kind except such as exception, defects,
mortgages, pledges, security interests, claims, restrictions or encumbrances (a) are described in
Pricing Disclosure Package and the Offering Memorandum or (b) do not, singly or in the aggregate,
have a Material Adverse Effect.

          (y) The Company and each of the significant subsidiaries is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as they reasonably
believe to be adequate for the conduct of their respective businesses and the value of their
properties and as they reasonably believe to be customary and consistent with industry standard.

8

 

          (z) The Company and each of its subsidiaries have such permits, licenses, patents, franchises,
certificates of need and other approvals or authorizations of governmental or regulatory
authorities (“Permits”) as are necessary under applicable law to own their properties and conduct
their businesses in the manner described in the Pricing Disclosure Package and the Offering
Memorandum, except for any of the foregoing that would not, in the aggregate, reasonably be
expected to have a Material Adverse Effect or except as described in the Pricing Disclosure Package
and the Offering Memorandum; each of the Company and its subsidiaries has fulfilled and performed
all of its obligations with respect to the Permits, and no event has occurred that allows, or after
notice or lapse of time would allow, revocation or termination thereof or results in any other
impairment of the rights of the holder or any such Permits, except for any of the foregoing that
would not reasonably be expected to have a Material Adverse Effect or except as described in the
Pricing Disclosure Package.

          (aa) The Company and each of its subsidiaries own or possess adequate rights to use all
material patents, patent applications, trademarks, service marks, trade names, trademark
registrations, service mark registrations, copyrights, licenses, know-how, software, systems and
technology (including trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) necessary for the conduct of their respective
businesses and have no reason to believe that the conduct of their respective businesses will
conflict with, and have not received any notice of any claim of conflict with, any such rights of
others, in each case, except as would not have a Material Adverse Effect.

          (bb) Except as described in the Pricing Disclosure Package and the Offering Memorandum, there
are no legal or governmental proceedings pending to which the Company or any of its subsidiaries is
a party or of which any property or assets of the Company or any of its subsidiaries is the subject
that would, in the aggregate, reasonably be expected to have a Material Adverse Effect; and to the
Company’s knowledge, no such proceedings are threatened or contemplated by governmental authorities
or others.

          (cc) Except as described in the Pricing Disclosure Package and the Offering Memorandum, there
is (x) no action, suit, proceeding, inquiry or investigation before or brought by any court or
governmental agency or body, now pending or, to the Company’s knowledge, threatened, against or
affecting the Company or any subsidiary that would be required to be described in a registration
statement of the Company pursuant to Item 103 of Regulation S-K that has not been described in the
Pricing Disclosure Package and the Offering Memorandum, and (y) there are no statutes, regulations,
contracts or other documents that would be required to be described in a registration statement of
the Company or to be filed as exhibits to a registration statement of the Company or to the
Company’s Annual Report on Form 10-K for the fiscal year ended on December 31, 2006 or the
Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007 that are not
described in the Pricing Disclosure Package or the Offering Memorandum or filed as required.

          (dd) Except as described in the Pricing Disclosure Package and the Offering Memorandum, no
labor disturbance by the employees of the Company or any of its subsidiaries exists or, to the
knowledge of the Company, is imminent that would reasonably be expected to have a Material Adverse
Effect.

9

 

          (ee) The Company and each of its significant subsidiaries has filed all material foreign,
federal, state and local tax returns that are required to be filed or have requested extensions
thereof (except in any case in which the failure so to file would not have a Material Adverse
Effect) and has paid all taxes required to be paid by it and any other assessment, fine or penalty
levied against it to the extent due and payable, except for any such assessment, fine or penalty
that is currently being contested in good faith or would not have a Material Adverse Effect.

          (ff) Neither the Company nor any of its subsidiaries (i) is in violation of its charter or
by-laws (or similar organizational documents), (ii) is in default, and no event has occurred that,
with notice or lapse of time or both, would constitute such a default, in the due performance or
observance of any term, covenant, condition or other obligation contained in any indenture,
mortgage, deed of trust, loan agreement, license or other agreement or instrument to which it is a
party or by which it is bound or to which any of its properties or assets is subject or (iii) is in
violation of any statute or any order, rule or regulation of any court or governmental agency or
body having jurisdiction over it or its property or assets or has failed to obtain any license,
permit, certificate, franchise or other governmental authorization or permit necessary to the
ownership of its property or to the conduct of its business, except in the case of clauses (ii) and
(iii), to the extent any such conflict, breach, violation or default would not, in the aggregate,
reasonably be expected to have a Material Adverse Effect.

          (gg) Except as described in Pricing Disclosure Package and the Offering Memorandum, neither
the Company nor any of its subsidiaries, nor, to the knowledge of the Company, any director,
officer, agent, employee or other person associated with or acting on behalf of the Company or any
of its subsidiaries, has (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political activity; (ii) made any direct or
indirect unlawful payment to any foreign or domestic government official or employee from corporate
funds; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of
1977; or (iv) made any bribe, rebate, payoff, influence payment, kickback or other unlawful
payment.

          (hh) There has been no storage, disposal, generation, manufacture, refinement, transportation,
handling or treatment of hazardous substances or hazardous wastes by the Company or any of its
subsidiaries (or, to the knowledge of the Company, any of their predecessors in interest), at, upon
or from any of the property now or previously owned, leased or operated by the Company or its
Subsidiaries in violation of any applicable law, ordinance, rule, regulation, order, judgment,
decree or permit that would require the Company or any subsidiary to undertake any remedial action
under any applicable law, ordinance, rule, regulation, order, judgment, decree or permit, except
for any violation or remedial action that would not, individually or in the aggregate with all such
violations and remedial actions, have a Material Adverse Effect. Except for abandonment and
similar costs incurred or to be incurred in the ordinary course of business of the Company and any
of its subsidiaries, there has been no material spill, discharge, leak, emission, injection,
escape, dumping or release of any kind onto any property now or previously owned, leased or
operated by the Company or any of its subsidiaries or into the environmental surrounding such
property of any hazardous substances or hazardous wastes due to or caused by the Company or any of
its subsidiaries (or, to the knowledge of the Company, any of their predecessors in interest),
except for any such spill,

10

 

discharge, leak, emission, injection, escape, dumping or release that would not, singularly or
in the aggregate with all such spills, discharges, leaks, emissions, injections, escapes, dumpings
and releases, result in a Material Adverse Effect; and the terms “hazardous substances,” and
“hazardous wastes” shall be construed broadly to include such terms and similar terms, all of which
shall have the meanings specified in any applicable local, state and federal laws or regulations
with respect to environmental protection.

          (ii) The Company and its affiliates have not taken, directly or indirectly, any action
designed to or that has constituted or that reasonably can be expected to cause or result in the
stabilization or manipulation of the price of any security of the Company in connection with the
offering of the Securities.

          (jj) Subject to such exceptions, if any, as could not reasonably be expected to have a
Material Adverse Effect, the Company (A) makes and keeps accurate books and records and (B)
maintains and has maintained effective internal control over financial reporting as defined in Rule
13a-5 under the Exchange Act and a system of internal accounting controls sufficient to provide
reasonable assurances that (i) transactions are executed in accordance with management’s general or
specific authorizations, (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to maintain
accountability for assets, (iii) access to assets is permitted only in accordance with management’s
general or specific authorization and (iv) the recorded accountability for assets is compared with
existing assets at reasonable intervals and appropriate action is taken with respect to any
differences; and, except as would not have a Material Adverse Effect, none of the Company, the
subsidiaries, or to the knowledge of the Company, any employee or agent thereof, has made any
payment of funds of the Company or the subsidiaries, or received or retained any funds, and no
funds of the Company or the subsidiaries have been set aside to be used for any payment, in each
case in violation of any law, rule or regulation.

          (kk) Since the date of the most recent balance sheet of the Company and its consolidated
subsidiaries reviewed or audited by Deloitte & Touche LLP and the audit committee of the board of
directors of the Company, (i) the Company has not been advised of (A) any significant deficiencies
in the design or operation of internal controls that would adversely affect the ability of the
Company or any of its subsidiaries to record, process, summarize and report financial data, or any
material weaknesses in internal controls or (B) any fraud, whether or not material, that involves
management or other employees who have a significant role in the internal controls of the Company
and each of its subsidiaries, and (ii) since that date, there have been no significant changes in
internal controls or in other factors that would significantly affect internal controls, including
any corrective actions with regard to significant deficiencies and material weaknesses.

          (ll) No subsidiary of the Company is currently prohibited, directly or indirectly, from paying
any dividends to the Company, from making any other distribution on such subsidiary’s capital
stock, from repaying to the Company any loans or advances to such subsidiary from the Company or
from transferring any of such subsidiary’s property or assets to the Company or any other
subsidiary of the Company, except as described in the Pricing Disclosure Package.

11

 

          (mm) There is and has been no failure on the part of the Company and any of the Company’s
directors or officers, in their capacities as such, to comply with the provisions of the
Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith.

          (nn) Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any
director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is
currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the
U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds
of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary,
joint venture partner or other person or entity, for the purpose of financing the activities of any
person currently subject to any U.S. sanctions administered by OFAC.

     Any certificate signed by any officer of the Company and delivered to the Representative or
counsel for the Initial Purchasers in connection with the offering of the Securities shall be
deemed a representation and warranty by the Company, as to matters covered thereby, to each Initial
Purchaser.

     3. Purchase of the Securities by the Initial Purchasers, Agreements to Sell, Purchase and
Resell.

          (a) The Company hereby agrees, on the basis of the representations, warranties and agreements
of the Initial Purchasers contained herein and subject to all the terms and conditions set forth
herein, to issue and sell to the Initial Purchasers and, upon the basis of the representations,
warranties and agreements of the Company herein contained and subject to all the terms and
conditions set forth herein, each Initial Purchaser agrees, severally and not jointly, to purchase
from the Company, at a purchase price of 98% of the principal amount thereof (the “Purchase
Price”), the total principal amount of Securities set forth opposite the name of such Initial
Purchaser in Schedule I hereto. The Company shall not be obligated to deliver any of the Firm
Securities to be delivered hereunder except upon payment for all of the Firm Securities to be
purchased as provided herein. On the basis of the representations and warranties contained in this
Agreement, and subject to its terms and conditions, the Company agrees to sell to the Initial
Purchasers the Additional Securities, and the Initial Purchasers shall have the right to purchase,
severally and not jointly, up to $50,000,000 aggregate principal amount of Additional Securities at
the Purchase Price. The Representative may exercise this right on behalf of the Initial Purchasers
to cover over-allotments in the sale of the Firm Securities in whole or from time to time in part
by giving written notice not later than 30 days after the date of this Agreement. Any exercise
notice shall specify the principal amount of Additional Securities to be purchased by the Initial
Purchasers and the date on which such Additional Securities are to be purchased. Each purchase
date must be at least one business day after the written notice is given and may not be earlier
than the closing date for the Firm Securities nor later than ten business days after the date of
such notice. Additional Securities may be purchased solely for the purpose of covering over
allotments made in connection with the offering of the Firm Securities. On each day, if any, that
Additional Securities are to be purchased (an “Option Closing Date”), each Initial Purchaser
agrees, severally and not jointly, to purchase the principal amount of Additional Securities
(subject to such adjustments to eliminate fractional Securities as you may determine) that bears
the same proportion to the total principal amount of Additional

12

 

Securities to be purchased on such Option Closing Date as the principal amount of Firm
Securities set forth in Schedule I opposite the name of such Initial Purchaser bears to the total
principal amount of Firm Securities.

          (b) Each of the Initial Purchasers, severally and not jointly, hereby represents and warrants
to the Company that it will offer the Securities for sale upon the terms and conditions set forth
in this Agreement, the Preliminary Offering Memorandum, the Pricing Disclosure Package and the
Offering Memorandum. Each of the Initial Purchasers hereby represents and warrants to, and agrees
with, the Company, on the basis of the representations, warranties and agreements of the Company,
that such Initial Purchaser: (i) is a QIB with such knowledge and experience in financial and
business matters as are necessary to evaluate the merits and risks of an investment in the
Securities; (ii) is purchasing the Securities pursuant to a private sale exempt from registration
under the Securities Act; (iii) in connection with the Exempt Resales, will solicit offers to buy
the Securities only from, and will offer to sell the Securities only to, the Eligible Purchasers in
accordance with this Agreement and on the terms contemplated by the Preliminary Offering
Memorandum, the Pricing Disclosure Package and the Offering Memorandum; and (iv) will not offer or
sell the Securities, nor has it offered or sold the Securities by, or otherwise engaged in, any
form of general solicitation or general advertising (within the meaning of Regulation D, including,
but not limited to, advertisements, articles, notices or other communications published in any
newspaper, magazine, or similar medium or broadcast over television or radio, or any seminar or
meeting whose attendees have been invited by any general solicitation or general advertising). The
Initial Purchasers have advised the Company that they will offer the Securities to Eligible
Purchasers at a price initially equal to 100% of the principal amount thereof, plus accrued
interest, if any, from the date of issuance of the Securities. Such price may be changed by the
Initial Purchasers at any time without notice.

          (c) Such Initial Purchaser has not nor, prior to the later to occur of (A) the Closing Date
and (B) completion of the distribution of the Securities, will not, use, authorize use of, refer to
or distribute any material in connection with the offering and sale of the Securities other than
(i) the Preliminary Offering Memorandum, the Pricing Disclosure Package, the Offering Memorandum,
(ii) any written communication that contains no “issuer information” (as defined in Rule 433(h)(2)
under the Act) that was not included (including through incorporation by reference) in the
Preliminary Offering Memorandum or any Free Writing Offering Document listed on Schedule III
hereto, (iii) the Free Writing Offering Documents listed on Schedule III hereto (which shall have
been approved by the Company prior to distribution), (iv) any written communication prepared by
such Initial Purchaser and approved by the Company in writing, or (v) any written communication
relating to or that contains the terms of the Securities and/or other information that was included
(including through incorporation by reference) in the Preliminary Offering Memorandum, the Pricing
Disclosure Package or the Offering Memorandum.

     Each of the Initial Purchasers understands that the Company and, for purposes of the opinions
to be delivered to the Initial Purchasers pursuant to Sections 7(a) and 7(b) hereof, counsel to the
Company and counsel to the Initial Purchasers, will rely upon the accuracy and truth of the
foregoing representations, warranties and agreements, and the Initial Purchasers hereby consent to
such reliance.

13

 

     4. Delivery of the Securities and Payment Therefor. Delivery to the Initial Purchasers of and
payment for the Firm Securities shall be made at the office of Davis Polk & Wardwell, 450 Lexington
Avenue, New York, New York, at 9:00 A.M., New York City time, on July 27, 2007 (the “Closing
Date”). The place of closing for the Securities and the Closing Date may be varied by agreement
between the Initial Purchasers and the Company.

     Payment for any Additional Securities shall be made to the Company against delivery of such
Additional Securities for the respective accounts of the several Initial Purchasers at 9:00 A.M.,
New York City time, on the date specified in the corresponding notice described in Section 3(a) or
at such other time on the same or on such other date, as may be varied by agreement between the
Initial Purchasers and the Company.

     The Securities will be delivered to the Initial Purchasers, or the Trustee as custodian for
The Depository Trust Company (“DTC”), against payment by or on behalf of the Initial Purchasers of
the Purchase Price therefor by wire transfer in immediately available funds, by causing DTC to
credit the applicable Securities to the account of the Initial Purchasers at DTC. The Securities
will be evidenced by one or more global securities in definitive form (the “Global Securities”) or
by additional definitive securities, and will be registered, in the case of the Global Securities,
in the name of Cede & Co. as nominee of DTC, and in the other cases, in such names and in such
denominations as the Initial Purchasers shall request prior to 9:30 A.M., New York City time, on
the second business day preceding the Closing Date or the Option Closing Date, as the case may be.
The Securities to be delivered to the Initial Purchasers shall be made available to the Initial
Purchasers in New York City for inspection and packaging not later than 9:30 A.M., New York City
time, on the business day next preceding the Closing Date or the Option Closing Date, as the case
may be.

     5. Agreements of the Company. The Company agrees with each of the Initial Purchasers as
follows:

          (a) The Company will furnish to the Initial Purchasers, without charge, within two business
days of the date of the Offering Memorandum, such number of copies of the Offering Memorandum as
may then be amended or supplemented as they may reasonably request.

          (b) The Company will not make any amendment or supplement to the Pricing Disclosure Package or
to the Offering Memorandum of which the Initial Purchasers shall not previously have been advised
or to which they shall reasonably object after being so advised.

          (c) The Company consents to the use of the Pricing Disclosure Package and the Offering
Memorandum in accordance with this Agreement and the securities or Blue Sky laws of the
jurisdictions in which the Securities are offered by the Initial Purchasers and by all dealers to
whom Securities may be sold, in connection with the offering and sale of the Securities.

          (d) If, at any time prior to completion of the distribution of the Securities by the Initial
Purchasers to Eligible Purchasers, any event occurs or information becomes known that, in the
judgment of the Company or the Initial Purchasers, should be set forth in the Pricing

14

 

Disclosure Package or the Offering Memorandum so that the Pricing Disclosure Package or the
Offering Memorandum, as then amended or supplemented, does not include any untrue statement of
material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading, or if it is necessary
to supplement or amend the Pricing Disclosure Package or the Offering Memorandum to comply with any
law, then the Company will forthwith prepare an appropriate supplement or amendment thereto, and
will expeditiously furnish to the Initial Purchasers and dealers a reasonable number of copies
thereof.

          (e) The Company will not make any offer to sell or solicitation of an offer to buy the
Securities that would constitute a Free Writing Offering Document without the prior consent of the
Representative, which consent shall not be unreasonably withheld or delayed; if at any time
following issuance of a Free Writing Offering Document any event occurred or occurs as a result of
which such Free Writing Offering Document conflicts with the information in the Preliminary
Offering Memorandum, the Pricing Disclosure Package or the Offering Memorandum or, when taken
together with the information in the Preliminary Offering Memorandum, the Pricing Disclosure
Package or the Offering Memorandum, includes an untrue statement of a material fact or omits to
state any material fact necessary in order to make the statements therein, in the light of the
circumstances then prevailing, not misleading, as promptly as practicable after becoming aware
thereof, the Company will give notice thereof to the Initial Purchasers through the Representative
and, if requested by the Representative, will prepare and furnish without charge to each Initial
Purchaser a Free Writing Offering Document or other document that will correct such conflict,
statement or omission.

          (f) Promptly from time to time to take such action as the Initial Purchasers may reasonably
request to qualify the Securities for offering and sale under the securities or Blue Sky laws of
such jurisdictions as the Initial Purchasers may reasonably request and to comply with such laws so
as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may
be necessary to complete the distribution of the Securities; provided that in connection therewith
the Company shall not be required to (i) qualify as a foreign corporation in any jurisdiction in
which it would not otherwise be required to so qualify, (ii) file a general consent to service of
process in any such jurisdiction or (iii) subject itself to taxation in any jurisdiction in which
it would not otherwise be subject.

          (g) For a period commencing on the date hereof and ending on the 60th day after the date of
the Offering Memorandum, the Company agrees not to, directly or indirectly, (1) offer for sale,
sell, or otherwise dispose of (or enter into any transaction or device that is designed to, or
would be expected to, result in the disposition by any person at any time in the future of) any
common stock (par value $0.01 per share) of the Company or securities convertible into or
exchangeable for such common stock of the Company, or sell or grant options, rights or warrants
with respect to the common stock of the Company or securities convertible into or exchangeable for
the common stock of the Company, (2) enter into any swap or other derivatives transaction that
transfers to another, in whole or in part, any of the economic benefits or risks of ownership of
the common stock of the Company, whether any such transaction described in clause (1) or (2) above
is to be settled by delivery of common stock securities of the Company or other securities, in cash
or otherwise, (3) file or cause to be filed a registration statement, including any amendments,
with respect to the registration of common

15

 

stock of the Company or securities convertible, exercisable or exchangeable into shares of
common stock of the Company or (3) publicly announce an offering of any shares of common stock of
the Company or securities convertible or exchangeable into shares of common stock of the Company,
in each case without the prior written consent of Lehman Brothers Inc., on behalf of the Initial
Purchasers, provided that the foregoing shall not apply to (A) the sale of the Securities under
this Agreement or the issuance of the Underlying Securities, (B) any grant or issuance of any stock
options, restricted stock or other awards, any issuance of shares of Common Stock of the Company
upon the exercise of options granted under, and any vesting of or removal or lapse of restrictions
on restricted stock or other awards under existing employee or director benefits plans or
agreements described in the Pricing Disclosure Package and the Offering Memorandum, (C) any
transfer of shares of Common Stock pursuant to the Company’s 401(k) plan described in the Pricing
Disclosure Package and the Offering Memorandum, (D) the filing by the Company of any registration
statement with the Commission on Form S-8 relating to the offering of securities pursuant to the
terms of the existing employee benefit plans or agreements described in the Pricing Disclosure
Package and the Offering Memorandum, (E) shares of Common Stock (or options, warrants or
convertible securities in respect thereof) issued in connection with a bona fide merger or
acquisition transaction, (F) the conversion of a security outstanding on the date hereof, or (G)
filing of any registration statement in respect of the Securities and the Underlying Securities.
Notwithstanding the foregoing, if (1) during the last 17 days of the 60-day restricted period, the
Company issues an earnings release or material news or a material event relating to the Company
occurs; or (2) prior to the expiration of the 60-day restricted period, the Company announces that
it will release earnings results during the 16-day period beginning on the last day of the 60-day
period, the restrictions imposed by this Agreement shall continue to apply until the expiration of
the 18 day period beginning on the issuance of the earnings release or the occurrence of the
material news or material event.

          (h) The Company will furnish to the holders of the Securities as soon as practicable after the
end of each fiscal year an annual report (including a balance sheet and statements of income,
stockholders’ equity and cash flows of the Company and its consolidated subsidiaries certified by
independent public accountants) and, as soon as practicable after the end of each of the first
three quarters of each fiscal year (beginning with the fiscal quarter ending after the date of the
Offering Memorandum), will make available to its securityholders consolidated summary financial
information of the Company and its subsidiaries for such quarter in reasonable detail; provided
that so long as the Company files periodic reports pursuant to Section 13 or 15(d) of the Exchange
Act for the foregoing periods, the Company shall be deemed to comply with this Section 5(h).

          (i) So long as any of the Securities or the Underlying Securities are outstanding, the Company
will furnish to the Initial Purchasers (i) as soon as available, a copy of each report of the
Company mailed to stockholders generally or filed with any stock exchange or regulatory body and
(ii) from time to time such other information concerning the Company as the Initial Purchasers may
reasonably request, except that if such reports are filed with, or furnished to, the SEC on EDGAR,
then such reports shall be deemed to have been delivered to the Initial Purchasers for purposes of
this Agreement.

16

 

           (j) The Company will apply the net proceeds from the sale of the Securities to be sold by it
hereunder substantially in accordance with the description set forth in the Pricing Disclosure
Package and the Offering Memorandum under the caption “Use of Proceeds.”

          (k) The Company and its affiliates will not take, directly or indirectly, any action designed
to or that has constituted or that reasonably would be expected to cause or result in the
stabilization or manipulation of the price of any security of the Company in connection with the
offering of the Securities.

          (l) The Company will use its best efforts to permit the Securities to be eligible for trading
through the Private Offerings, Resales and Trading through Automated Linkages (PORTAL)
MarketSM (the “PORTAL MarketSM”).

          (m) Without the prior written consent of Lehman Brothers Inc., on behalf of the Initial
Purchasers, the Company will not, and will not permit any of its affiliates (as defined in Rule 144
under the Securities Act) for a period of two years following the Closing Date, or the date of sale
of any Additional Securities, as applicable, to resell any of the Securities that have been
acquired by any of them, except for Securities purchased by the Company or any of its affiliates
and resold in a transaction registered under the Securities Act.

          (n) The Company agrees not to sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in the Securities Act) that would be integrated
with the sale of the Securities in a manner that would require the registration under the
Securities Act of the sale to the Initial Purchasers or the Eligible Purchasers of the Securities.

     6. Expenses. Whether or not the transactions contemplated by this Agreement are consummated
or this Agreement becomes effective or is terminated, the Company agrees, to pay all costs,
expenses, fees and taxes incident to and in connection with: (i) the preparation, printing, filing
and distribution of the Preliminary Offering Memorandum, the Pricing Disclosure Package and the
Offering Memorandum (including, without limitation, financial statements and exhibits) and all
amendments and supplements thereto (including the fees, disbursements and expenses of the Company’s
accountants and counsel, but not, however, legal fees and expenses of the Initial Purchasers’
counsel incurred in connection therewith); (ii) the preparation, printing (including, without
limitation, word processing and duplication costs) and delivery of this Agreement, the Indenture,
the Registration Rights Agreement, all Blue Sky memoranda and all other agreements, memoranda,
correspondence and other documents printed and delivered in connection therewith and with the
Exempt Resales (but not, however, legal fees and expenses of the Initial Purchasers’ counsel
incurred in connection with any of the foregoing other than fees of such counsel plus reasonable
disbursements incurred in connection with the preparation, printing and delivery of such Blue Sky
memoranda); (iii) the issuance and delivery by the Company of the Securities and any taxes payable
in connection therewith; (iv) the qualification of the Securities for offer and sale under the
securities or Blue Sky laws of the several states (including, without limitation, the reasonable
fees and disbursements of the Initial Purchasers’ counsel relating to such registration or
qualification); (v) the furnishing of such copies of the Pricing Disclosure Package and the
Offering Memorandum, and all amendments and supplements thereto, as may be reasonably requested for
use in connection with the Exempt Resales; (vi) the preparation of certificates for the Securities
(including, without limitation, printing and

17

 

engraving thereof); (vii) the application for quotation of the Securities in the PORTAL
MarketSM (including all disbursements and listing fees); (viii) the approval of the
Securities by DTC for “book-entry” transfer (other than the fees and disbursements of the Initial
Purchaser’s counsel relating to such approval); (ix) the rating of the Securities; (x) the
obligations of the Trustee, any agent of the Trustee and the counsel for the Trustee in connection
with the Indenture and the Securities; (xi) the performance by the Company of their other
obligations under this Agreement; and (xii) all expenses associated with any electronic road show.

     7. Conditions to Initial Purchasers’ Obligations. The respective obligations of the Initial
Purchasers hereunder are subject to the accuracy, on and as of the Closing Date and, with respect
to the Additional Securities, on each Option Closing Date, as if made on and as of the Closing Date
or the Option Closing Date, of the representations and warranties of the Company contained herein,
to the performance by the Company of its obligations hereunder, and to each of the following
additional terms and conditions:

          (a) Each of Vinson & Elkins LLP, as counsel to the Company, Russell J. Robicheaux, as Chief
Administrative Officer and General Counsel to the Company and Myers & Alberga, as special Cayman
Islands counsel to the Company, shall have furnished to the Initial Purchasers their written
opinion letter, addressed to the Initial Purchasers and dated the Closing Date and any Option
Closing Date, substantially in the form of Exhibits B, C and D hereto;

          (b) The Initial Purchasers shall have received from Davis Polk & Wardwell, counsel for the
Initial Purchasers, such opinion or opinions, dated the Closing Date and any Option Closing Date,
with respect to the issuance and sale of the Securities, the Pricing Disclosure Package, the
Offering Memorandum and other related matters as the Initial Purchasers may reasonably require, and
the Company shall have furnished to such counsel such documents and information as they reasonably
request for the purpose of enabling them to pass upon such matters.

          (c) At the time of execution of this Agreement, the Initial Purchasers shall have received
from Deloitte & Touche LLP a letter, in form and substance reasonably satisfactory to the Initial
Purchasers, addressed to the Initial Purchasers and dated the date hereof (i) confirming that they
are independent public accountants within the meaning of the Securities Act and are in compliance
with the applicable requirements relating to the qualification of accountants under Rule 2-01 of
Regulation S-X of the Commission and (ii) stating, as of the date hereof (or, with respect to
matters involving changes or developments since the respective dates as of which specified
financial information is given in the Pricing Disclosure Package, as of a date not more than three
business days prior to the date hereof), the conclusions and findings of such firm with respect to
the financial information and (iii) covering such other matters as are ordinarily covered by
accountants’ “comfort letters” to underwriters in connection with registered public offerings.

          (d) With respect to the letter of Deloitte & Touche LLP referred to in the preceding paragraph
and delivered to the Initial Purchasers concurrently with the execution of this Agreement (the
“initial letter”), the Initial Purchasers shall have received a letter (the “bring-down letter”) of
such accountants, addressed to the Initial Purchasers and dated the Closing Date and any Option
Closing Date (i) confirming that they are independent public

18

 

accountants within the meaning of the Securities Act and are in compliance with the applicable
requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X of the
Commission, (ii) stating, as of the Closing Date (or, with respect to matters involving changes or
developments since the respective dates as of which specified financial information is given in
each of the Pricing Disclosure Package or the Offering Memorandum, as of a date not more than three
business days prior to the date of the Closing Date), the conclusions and findings of such firm
with respect to the financial information and other matters covered by the initial letter and (iii)
confirming in all material respects the conclusions and findings set forth in the initial letter.

          (e) Since the respective dates as of which information is given in the Pricing Disclosure
Package and the Offering Memorandum (excluding any amendment or supplement thereto after the date
hereof) there shall not have been any change in the capital stock or long-term debt of the Company
or any of its subsidiaries or any change, or any development involving a prospective change, in or
affecting the condition (financial or otherwise), results of operations, stockholders’ equity,
properties, management or business of the Company and its subsidiaries, taken as a whole, the
effect of which is, individually or in the aggregate, in the judgment of the Representative, so
material and adverse as to make it impracticable or inadvisable to proceed with the offering or the
delivery of the Securities being delivered on the Closing Date on the terms and in the manner
contemplated in the Pricing Disclosure Package and the Offering Memorandum.

          (f) The Company shall have furnished or caused to be furnished to the Initial Purchasers on
the Closing Date a certificate of an officer of the Company satisfactory to the Initial Purchasers
certifying that:

     (i) The representations, warranties and agreements of the Company in Section 2 are true
and correct on and as of the Closing Date and any Option Closing Date, and the Company has
complied with all its agreements contained herein and satisfied all the conditions on its
part to be performed or satisfied hereunder at or prior to the Closing Date and any Option
Closing Date; and

     (ii) They have carefully examined the Pricing Disclosure Package and the Offering
Memorandum, and, in their opinion since the date of the Pricing Disclosure Package and the
Offering Memorandum, no event has occurred which should have been set forth in a supplement
or amendment to the Pricing Disclosure Package or the Offering Memorandum.

          (g) The Securities shall have been designated for trading on the PORTAL MarketSM,
subject only to notice of issuance at or prior to the time of purchase.

          (h) The Company shall have executed and delivered the Registration Rights Agreement, and the
Initial Purchasers shall have received an original copy thereof, duly executed by the Company.

19

 

          (i) The Company and the Trustee shall have executed and delivered the Indenture, and the
Initial Purchasers shall have received an original copy thereof, duly executed by the Company and
the Trustee.

          (j) Subsequent to the execution and delivery of this Agreement there shall not have occurred
any of the following: (i) trading in securities generally on the New York Stock Exchange, or
trading in any securities of the Company on The Nasdaq Global Select Market, shall have been
suspended or materially limited or minimum prices shall have been established on the New York Stock
Exchange or the Nasdaq Global Select Market by the Commission, by such exchange or by any other
regulatory body or governmental authority having jurisdiction, (ii) a banking moratorium shall have
been declared by federal or New York authorities, or (iii) there shall have been an escalation in
hostilities involving the United States or there shall have been a declaration of a national
emergency or war by the United States or (iv) there shall have occurred such a material adverse
change in general economic, political or financial conditions, including, without limitation, as a
result of terrorist activities after the date hereof (or the effect of international conditions on
the financial markets in the United States shall be such), as to make it, in the judgment of the
Representative, impracticable or inadvisable to proceed with the offering or delivery of the
Securities being delivered on the Closing Date on the terms and in the manner contemplated in the
Offering Memorandum.

          (k) On the Closing Date, the Company shall have obtained an approval and consent (the “Credit
Agreement Waiver”), from the lenders under its existing credit facility dated as of June 30, 2006
as amended by Amendment No. 1 thereto dated as of October 6, 2006, by and among the Company, Global
Offshore Mexico, S. de R.L. de C.V., Global Industries International, L.P., Calyon New York Branch,
as administrative agent for the lenders and issuing bank and the other financial institutions party
thereto to permit the issuance of the Securities and the Credit Agreement Waiver will have been
delivered and will be in full force and effect.

          (l) On or prior to the date hereof, the Company shall have furnished to Lehman Brothers Inc.
an agreement in the form of Exhibit E hereto from each of the Company’s directors and executive
officers, and such agreement shall be in full force and effect on each of the Closing Date and any
Option Closing Date.

     All opinions, letters, evidence and certificates mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Initial Purchasers.

     The several obligations of the Initial Purchasers to purchase Additional Securities hereunder
are subject to the delivery to the Representative on the applicable Option Closing Date of such
documents as the Representative may reasonably request with respect to the good standing of the
Company, the due authorization and issuance of the Additional Securities to be sold on such Option
Closing Date and other matters related to the issuance of such Additional Securities.

20

 

     8. Indemnification and Contribution.

          (a) The Company hereby agrees to indemnify and hold harmless each Initial Purchaser, its
directors, officers and employees and each person, if any, who controls any Initial Purchaser
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and
against any loss, claim, damage or liability, joint or several, or any action in respect thereof,
to which that Initial Purchaser, director, officer, employee or controlling person may become
subject, under the Securities Act, the Exchange Act or otherwise, insofar as such loss, claim,
damage, liability or action arises out of, or is based upon, (i) any untrue statement or alleged
untrue statement of a material fact contained (A) in any Free Writing Offering Document, the
Preliminary Offering Memorandum, the Pricing Disclosure Package or the Offering Memorandum or in
any amendment or supplement thereto, (B) in any Blue Sky application or other document prepared or
executed by the Company (or based upon any written information furnished by the Company)
specifically for the purpose of qualifying any or all of the Securities under the securities laws
of any state or other jurisdiction (any such application, document or information being hereinafter
called a “Blue Sky Application”) or (C) in any materials or information provided to investors by,
or with the written approval of, the Company in connection with the marketing of the offering of
the Securities (“Marketing Materials”), including any roadshow or investor presentations made to
investors by the Company (whether in person or electronically), or (ii) the omission or alleged
omission to state in any Free Writing Offering Document, the Preliminary Offering Memorandum, the
Pricing Disclosure Package or the Offering Memorandum, or in any amendment or supplement thereto,
or in any Blue Sky Application or in any Marketing Materials, any material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not
misleading, and shall reimburse each Initial Purchaser and each such director, officer, employee or
controlling person promptly upon demand for any legal or other expenses reasonably incurred by that
Initial Purchaser, director, officer, employee or controlling person in connection with
investigating or defending or preparing to defend against any such loss, claim, damage, liability
or action as such expenses are incurred; provided, that the Company shall not be liable in any such
case to the extent that any such loss, claim, damage, liability or action arises out of, or is
based upon, any untrue statement or alleged untrue statement or omission or alleged omission made
in any Free Writing Offering Document, Preliminary Offering Memorandum, the Pricing Disclosure
Package or Offering Memorandum, or in any such amendment or supplement thereto, or in any Blue Sky
Application or in any Marketing Materials, in reliance upon and in conformity with written
information concerning such Initial Purchaser furnished to the Company through the Representative
by or on behalf of any Initial Purchaser specifically for inclusion therein, which information
consists solely of the information specified in Section 8(e). The foregoing indemnity agreement is
in addition to any liability that the Company may otherwise have to any Initial Purchaser or to any
director, officer, employee or controlling person of that Initial Purchaser.

          (b) Each Initial Purchaser, severally and not jointly, hereby agrees to indemnify and hold
harmless the Company, its officers and employees, each of its directors, and each person, if any,
who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any
action in respect thereof, to which the Company or any such director, officer, employee or
controlling person may become subject, under the Securities Act,

21

 

the Exchange Act or otherwise, insofar as such loss, claim, damage, liability or action arises
out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact
contained (A) in any Free Writing Offering Document, Preliminary Offering Memorandum, the Pricing
Disclosure Package or the Offering Memorandum or in any amendment or supplement thereto, (B) in any
Blue Sky Application, or (C) in any Marketing Materials or (ii) the omission or alleged omission to
state in any Free Writing Offering Document, Preliminary Offering Memorandum, the Pricing
Disclosure Package or the Offering Memorandum, or in any amendment or supplement thereto, or in any
Blue Sky Application or in any Marketing Materials any material fact necessary to make the
statements therein not misleading, but in each case only to the extent that the untrue statement or
alleged untrue statement or omission or alleged omission was made in reliance upon and in
conformity with written information concerning such Initial Purchaser furnished to the Company
through the Representative by or on behalf of that Initial Purchaser specifically for inclusion
therein, which information is limited to the information set forth in Section 8(e). The foregoing
indemnity agreement is in addition to any liability that any Initial Purchaser may otherwise have
to the Company or any such director, officer, employee or controlling person.

          (c) Promptly after receipt by an indemnified party under this Section 8 of notice of any claim
or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to
be made against the indemnifying party under this Section 8, notify the indemnifying party in
writing of the claim or the commencement of that action; provided, that the failure to notify the
indemnifying party shall not relieve it from any liability that it may have under this Section 8
except to the extent it has been materially prejudiced by such failure and; provided, further, that
the failure to notify the indemnifying party shall not relieve it from any liability that it may
have to an indemnified party otherwise than under this Section 8. If any such claim or action
shall be brought against an indemnified party, and it shall notify the indemnifying party thereof,
the indemnifying party shall be entitled to participate therein and, to the extent that it wishes,
jointly with any other similarly notified indemnifying party, to assume the defense thereof with
counsel reasonably satisfactory to the indemnified party. After notice from the indemnifying party
to the indemnified party of its election to assume the defense of such claim or action, the
indemnifying party shall not be liable to the indemnified party under this Section 8 for any legal
or other expenses subsequently incurred by the indemnified party in connection with the defense
thereof other than reasonable costs of investigation; provided, that the indemnified party shall
have the right to employ counsel to represent jointly the indemnified party and their or its
respective directors, officers, employees and controlling persons who may be subject to liability
arising out of any claim, if (i) the indemnifying party and the indemnified party shall have so
mutually agreed; (ii) the indemnifying party has failed within a reasonable time to retain counsel
reasonably satisfactory to the indemnified party; (iii) the indemnified party and their or its
respective directors, officers, employees and controlling persons shall have reasonably concluded,
based on the advice of counsel, that there may be legal defenses available to them that are
different from or in addition to those available to the indemnifying party; or (iv) the named
parties in any such proceeding (including any impleaded parties) include both the indemnified party
or their or its respective directors, officers, employees or controlling persons, on the one hand,
and the indemnifying party, on the other hand, and representation of both sets of parties by the
same counsel would present a conflict due to actual or potential differing interests between them,
and in any such event the fees and expenses of such separate counsel shall be paid by the
indemnifying party, provided that the Company shall not be liable for the fees and

22

 

expenses of more than one separate counsel in the same jurisdiction. No indemnifying party
shall (x) without the prior written consent of the indemnified parties (which consent shall not be
unreasonably withheld), settle or compromise or consent to the entry of any judgment with respect
to any pending or threatened claim, action, suit or proceeding in respect of which indemnification
or contribution may be sought hereunder (whether or not the indemnified parties are actual or
potential parties to such claim or action) unless such settlement, compromise or consent includes
an unconditional release of each indemnified party from all liability arising out of such claim,
action, suit or proceeding, or (y) be liable for any settlement of any such action effected without
its written consent (which consent shall not be unreasonably withheld), but if settled with the
consent of the indemnifying party or if there be a final judgment of the plaintiff in any such
action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and
against any loss or liability by reason of such settlement or judgment.

          (d) If the indemnification provided for in this Section 8 shall for any reason be unavailable
to or insufficient to hold harmless an indemnified party under Section 8(a) or 8(b) in respect of
any loss, claim, damage or liability, or any action in respect thereof, referred to therein, then
each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the
amount paid or payable by such indemnified party as a result of such loss, claim, damage or
liability, or action in respect thereof, (i) in such proportion as shall be appropriate to reflect
the relative benefits received by the Company, on the one hand, and the Initial Purchasers, on the
other, from the offering of the Securities or (ii) if the allocation provided by clause (i) above
is not permitted by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause (i) above but also the relative fault of the Company, on
the one hand, and the Initial Purchasers, on the other, with respect to the statements or omissions
that resulted in such loss, claim, damage or liability, or action in respect thereof, as well as
any other relevant equitable considerations. The relative benefits received by the Company, on the
one hand, and the Initial Purchasers, on the other, with respect to such offering shall be deemed
to be in the same proportion as the total net proceeds from the offering of the Securities
purchased under this Agreement (before deducting expenses) received by the Company, on the one
hand, and the total underwriting discounts and commissions received by the Initial Purchasers with
respect to the Securities purchased under this Agreement, on the other hand, bear to the total
gross proceeds from the offering of the Securities under this Agreement as set forth on the cover
page of the Offering Memorandum. The relative fault shall be determined by reference to whether
the untrue or alleged untrue statement of a material fact or omission or alleged omission to state
a material fact relates to information supplied by the Company, or the Initial Purchasers, the
intent of the parties and their relative knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Company and the Initial Purchasers agree that
it would not be just and equitable if contributions pursuant to this Section 8(d) were to be
determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for
such purpose) or by any other method of allocation that does not take into account the equitable
considerations referred to herein. The amount paid or payable by an indemnified party as a result
of the loss, claim, damage or liability, or action in respect thereof, referred to above in this
Section 8(d) shall be deemed to include, for purposes of this Section 8(d), any legal or other
expenses reasonably incurred by such indemnified party in connection with investigating or
defending any such action or claim. Notwithstanding the provisions of this Section 8(d), no
Initial Purchaser shall be required to

23

 

contribute any amount in excess of the amount by which the net proceeds from the sale to
Eligible Purchasers of the Securities initially purchased by it exceeds the amount of any damages
that such Initial Purchaser has otherwise paid or become liable to pay by reason of any untrue or
alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The Initial
Purchasers’ obligations to contribute as provided in this Section 8(d) are several in proportion to
their respective underwriting obligations and not joint.

          (e) The Initial Purchasers severally confirm and the Company acknowledges and agrees that the
statements with respect to the offering of the Securities by the Initial Purchasers set forth in
the in the Pricing Disclosure Package and the Offering Memorandum contained in the last sentence on
the cover page of the Offering Memorandum, in the third paragraph of the section entitled “Plan of
Distribution” and in the first paragraph under the caption “Plan of Distribution—Stabilization,
Short Positions, Market Making and Trading” in the Offering Memorandum constitute the only
information concerning such Initial Purchasers furnished in writing to the Company by or on behalf
of the Initial Purchasers specifically for inclusion in the Preliminary Offering Memorandum, the
Pricing Disclosure Package and the Offering Memorandum or in any amendment or supplement thereto.

     9. Defaulting Initial Purchasers. If on the Closing Date, or on an Option Closing Date, as
the case may be, any Initial Purchaser defaults in the performance of its obligations under this
Agreement, the remaining non-defaulting Initial Purchasers shall be obligated to purchase the
Securities that the defaulting Initial Purchaser agreed but failed to purchase on the Closing Date
or the Option Closing Date, as the case may be, in the respective proportions that the principal
amount of Securities set opposite the name of each remaining non-defaulting Initial Purchaser in
Schedule I hereto bears to the total principal amount of Securities set opposite the names of all
the remaining non-defaulting Initial Purchasers in Schedule I hereto; provided, that the remaining
non-defaulting Initial Purchasers shall not be obligated to purchase any of the Securities on the
Closing Date or the Option Closing Date, as the case may be, if the aggregate principal amount of
Securities that the defaulting Initial Purchaser or Initial Purchasers agreed but failed to
purchase on such date exceeds 9.09% of the aggregate principal amount of Securities to be purchased
on the Closing Date, or on the Option Closing Date, as the case may be, and any remaining
non-defaulting Initial Purchasers shall not be obligated to purchase more than 110% of the
aggregate principal amount of Securities that it agreed to purchase on the Closing Date, or on the
Option Closing Date, as the case may be, pursuant to the terms of Section 3. If the foregoing
maximums are exceeded, the remaining non-defaulting Initial Purchasers, or those other Initial
Purchasers satisfactory to the Initial Purchasers who so agree, shall have the right, but shall not
be obligated, to purchase, in such proportion as may be agreed upon among them, all the Securities
to be purchased on the Closing Date, or on the Option Closing Date, as the case may be.

     If other Initial Purchasers are obligated or agree to purchase the Securities of a defaulting
or withdrawing Initial Purchaser, either the remaining Initial Purchasers or the Company may
postpone the Closing Date for up to seven full business days in order to effect any changes that in
the opinion of counsel for the Company or counsel for the Initial Purchasers may be necessary

24

 

in the Pricing Disclosure Package, the Offering Memorandum or in any other document or
arrangement.

     If the remaining Initial Purchasers or other Initial Purchasers satisfactory to the Initial
Purchasers do not elect to purchase: (a) the Securities that the defaulting Initial Purchaser or
Initial Purchasers agreed but failed to purchase on the Closing Date, this Agreement shall
terminate without liability on the part of any non-defaulting Initial Purchaser or the Company; or
(b) the Additional Securities that the defaulting Initial Purchaser or Initial Purchasers agreed
but failed to purchase on the Option Closing Date, the non-defaulting Initial Purchasers shall
have, the option to either: (i) terminate their obligation hereunder to purchase the Additional
Securities to be sold on such Option Closing Date; or (ii) purchase not less than the principal
amount of Additional Securities that such non-defaulting Initial Purchaser would have been
obligated to purchase in the absence of such default.

     As used in this Agreement, the term “Initial Purchaser” includes, for all purposes of this
Agreement unless the context requires otherwise, any party not listed in Schedule I hereto that,
pursuant to this Section 10, purchases Securities that a defaulting Initial Purchaser agreed but
failed to purchase.

     Nothing contained herein shall relieve: (a) a defaulting Initial Purchaser of any liability it
may have to the Company for damages caused by its default; or (b) the Company of any liability for
the payment of expenses to the extent set forth in Sections 8 and 11.

     10. Termination. The obligations of the Initial Purchasers hereunder may be terminated by the
Initial Purchasers by notice given to and received by the Company prior to delivery of and payment
for the Securities if, prior to that time, any of the events described in Sections 7(e) or (j)
shall have occurred or if the Initial Purchasers shall decline to purchase the Securities for any
reason permitted under this Agreement.

     11. Reimbursement of Initial Purchasers’ Expenses. If (a) the Company fails to tender the
Securities for delivery to the Initial Purchasers or (b) the Initial Purchasers shall decline to
purchase the Securities for any reason permitted under this Agreement, the Company shall reimburse
the Initial Purchasers for all reasonable out-of-pocket expenses (including fees and disbursements
of counsel) incurred by the Initial Purchasers in connection with this Agreement and the proposed
purchase of the Securities, and upon demand the Company shall pay the full amount thereof to the
Initial Purchasers.

     12. Notices, etc. All statements, requests, notices and agreements hereunder shall be in
writing, and:

          (a) if to any Initial Purchaser, shall be delivered or sent by hand delivery, mail, telex,
overnight courier or facsimile transmission to Lehman Brothers Inc., 745 Seventh Avenue, New York,
New York 10019, Attention: Syndicate Registration (Fax: 646-834-8133) with a copy to Davis Polk
& Wardwell, Attention: Alan Dean (Fax: 212-450-3800), and with a copy, in the case of any notice
pursuant to Section 8(c), to the Director of Litigation, Office of the General Counsel, Lehman
Brothers Inc., 399 Park Avenue, 10th Floor, New York, New York 10022 (Fax: 212-520-0421);

25

 

          (b) if to the Company, shall be delivered or sent by mail, telex, overnight courier or
facsimile transmission to Global Industries, Ltd, 8000 Global Drive, Carlyss, Louisiana 70665,
Attention: Russell J. Robicheaux (Fax: 281-529-7980), with a copy to Vinson & Elkins LLP, 2300
First City Tower, 1001 Fannin Street, Houston, Texas 77002, Attention: Jeffery B. Floyd (Fax:
713-615-2194);

provided, that any notice to an Initial Purchaser pursuant to Section 8(c) shall be delivered or
sent by hand delivery, mail, telex or facsimile transmission to such Initial Purchaser at its
address set forth in its acceptance telex to Lehman Brothers Inc., which address will be supplied
to any other party hereto by Lehman Brothers Inc. upon request. Any such statements, requests,
notices or agreements shall take effect at the time of receipt thereof. The Company shall be
entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of
the Initial Purchasers by Lehman Brothers Inc.

     13. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of
and be binding upon the Initial Purchasers, the Company, and their respective successors. This
Agreement and the terms and provisions hereof are for the sole benefit of only those persons,
except that the representations, warranties, indemnities and agreements of the Company contained in
this Agreement shall also be deemed to be for the benefit of directors, officers and employees of
the Initial Purchasers and each person or persons, if any, controlling any Initial Purchaser within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act. Nothing in this
Agreement is intended or shall be construed to give any person, other than the persons referred to
in this Section 13, any legal or equitable right, remedy or claim under or in respect of this
Agreement or any provision contained herein.

     14. Survival. The respective indemnities, representations, warranties and agreements of the
Company and the Initial Purchasers contained in this Agreement or made by or on behalf on them,
respectively, pursuant to this Agreement, shall survive the delivery of and payment for the
Securities and shall remain in full force and effect, regardless of any investigation made by or on
behalf of any of them or any person controlling any of them.

     15. Definition of the Terms “Business Day,” “Affiliate” and “Subsidiary.” For purposes of
this Agreement, (a) “business day” means any day on which the New York Stock Exchange, Inc. is open
for trading and (b) “affiliate” and “subsidiary” have the meanings set forth in Rule 405 under the
Securities Act.

     16. Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of New York.

     17. No Fiduciary Duty. The Company acknowledges and agrees that in connection with this
offering, or any other services the Initial Purchasers may be deemed to be providing hereunder,
notwithstanding any preexisting relationship, advisory or otherwise, between the parties or any
oral representations or assurances previously or subsequently made by the Initial Purchasers: (i)
no fiduciary or agency relationship between the Company, and any other person, on the one hand, and
the Initial Purchasers, on the other, exists; (ii) the Initial Purchasers are not acting as
advisors, expert or otherwise, to the Company, including, without limitation, with respect to the
determination of the purchase price of the Securities, and such relationship

26

 

between the Company, and the Initial Purchasers is entirely and solely commercial, based on
arms-length negotiations; (iii) any duties and obligations that the Initial Purchasers may have to
the Company shall be limited to those duties and obligations specifically stated herein; and (iv)
the Initial Purchasers and their respective affiliates may have interests that differ from those of
the Company. The Company hereby waive any claims that the Company may have against the Initial
Purchasers with respect to any breach of fiduciary duty in connection with the Securities.

     18. Counterparts. This Agreement may be executed in one or more counterparts and, if executed
in more than one counterpart, the executed counterparts shall each be deemed to be an original but
all such counterparts shall together constitute one and the same instrument.

     19. Headings. The headings herein are inserted for convenience of reference only and are not
intended to be part of, or to affect the meaning or interpretation of, this Agreement.

27

 

     If the foregoing correctly sets forth the agreement between the Company and the Initial
Purchasers, please indicate your acceptance in the space provided for that purpose below.

	 	 	 	 	 
	 	Very truly yours,

GLOBAL INDUSTRIES, LTD.

 	 
	 	By  	/s/  Peter S. Atkinson	 
	 	 	Name:  	Peter S. Atkinson	 
	 	 	Title:  	President and Chief Financial Officer	 

	 	 	 	 	 	 
	Accepted:

Lehman Brothers Inc.

Calyon Securities (USA) Inc.

Fortis Securities LLC

Natexis Bleichroeder

	 
	By Lehman Brothers Inc., as Authorized Representative

 	 	 
	By  	 	/s/  Arlene
Salmonson	 	 
	 	 	Name:  	Arlene Salmonson	 
	 	 	Title:  	Vice President	 
	 

28

 

SCHEDULE I

	 	 	 	 	 
	 	 	Principal	 
	 	 	Amount of	 
	 	 	Firm Securities	 
	 	 	to be	 
	 Initial Purchasers	 	Purchased	 
	Lehman Brothers Inc.
	 	$	260,000,000	 
	Calyon Securities (USA) Inc.
	 	 	32,500,000	 
	Natexis Bleichroeder Inc.
	 	 	19,500,000	 
	Fortis Securities LLC
	 	 	13,000,000	 
	 
	 	 	 
	Total
	 	$	325,000,000	 
	 
	 	 	 

 

SCHEDULE II

GLOBAL INDUSTRIES, LTD.

$325,000,000

2.75% Senior Convertible Debentures due 2027

	 	 	 
	Issuer:
	 	Global Industries, Ltd.
	 
	Common stock symbol:
	 	GLBL
	 
	Title of securities:
	 	2.75% Senior Convertible Debentures due 2027
	 
	Aggregate principal amount offered:
	 	$325,000,000
	 
	Principal amount per debenture:
	 	$1,000
	 
	Issue price:
	 	100%
	 
	Over-allotment option:
	 	$50,000,000
	 
	Net proceeds:
	 	$318.1 million ($367.1 million if the initial purchasers exercise their option to purchase additional debentures in full)
	 
	Annual interest rate:
	 	2.75% per annum accruing from July 27, 2007
	 
	Conversion premium:
	 	32.50%
	 
	Reference price:
	 	$26.78
	 
	Conversion price:
	 	$35.48 per share of common stock
	 
	Conversion rate:
	 	28.1821 shares of common stock per $1,000 aggregate principal amount of debentures
	 
	Interest payment dates:
	 	February 1 and August 1
	 
	Maturity:
	 	August 1, 2027
	 
	Call feature:
	 	Issuer may redeem the debentures on or after August 1, 2014 at 100% of the principal amount plus accrued interest
	 
	Put dates:
	 	Holders may require the issuer to repurchase all or a portion of their debentures on August 1, 2017 and August 1, 2022 at 100% of the principal amount plus accrued interest
	 
	Ranking:
	 	Senior unsecured, equal in right of payment with all of Global Industries, Ltd.'s existing and future senior unsecured indebtedness.
	 
	Use of proceeds:
	 	Global Industries, Ltd. intends to use up to $75.0 million of the net proceeds to repurchase shares of its common stock, including shares sold short
by purchasers of the debentures, and the remainder of the net proceeds for general corporate purposes, which may include upgrading existing vessels,
vessel acquisitions, new vessel construction, including construction of the recently announced Global 1200, and acquisitions of industry-related businesses.
	 
	Trade date:
	 	July 23, 2007
	 
	Settlement date:
	 	July 27, 2007
	 
	CUSIP:
	 	•            144A Senior Convertible Debenture due 2027: 379336 AD2
	 
	 
	 	•                 144A Common Stock: 379336 209
	 
	 
	 	•                  Senior Convertible Debenture due 2027: 379336 AE0
	 
	Initial Purchasers:
	 	Lehman Brothers Inc. (Bookrunner)
	 
	 	Calyon Securities (USA) Inc. (Co-manager)

II-1

 

	 	 	 
	 
	 	Fortis Securities LLC. (Co-manager)
	 
	 	Natexis Bleichroeder Inc. (Co-manager)
	 
	Adjustment to conversion rate upon a Non-Stock Change in Control:
	 	The following table sets forth the number of additional shares by which the conversion rate will be increased upon a conversion in connection with a
non-stock change of control occurring prior to August 1, 2014 based on the effective date of the change of control and the stock price paid per
share in the non-stock change of control:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Effective Date	 	Stock Price	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	$26.78	 	$30.00	 	$35.48	 	$40.00	 	$50.00	 	$60.00	 	$70.00	 	$80.00	 	$90.00	 	$100.00	 	$110.00	 	$120.00	 	$130.00
	07/27/2007
	 	 	9.1591	 	 	 	7.5439	 	 	 	5.6369	 	 	 	4.5696	 	 	 	3.0743	 	 	 	2.2125	 	 	 	1.6671	 	 	 	1.2966	 	 	 	1.0323	 	 	 	0.8355	 	 	 	0.6843	 	 	 	0.5654	 	 	 	0.4699	 
	08/01/2008
	 	 	8.8706	 	 	 	7.2270	 	 	 	5.3103	 	 	 	4.2534	 	 	 	2.8016	 	 	 	1.9874	 	 	 	1.4832	 	 	 	1.1465	 	 	 	0.9088	 	 	 	0.7330	 	 	 	0.5991	 	 	 	0.4940	 	 	 	0.4097	 
	08/01/2009
	 	 	8.5095	 	 	 	6.8345	 	 	 	4.9104	 	 	 	3.8696	 	 	 	2.4771	 	 	 	1.7238	 	 	 	1.2705	 	 	 	0.9751	 	 	 	0.7691	 	 	 	0.6192	 	 	 	0.5053	 	 	 	0.4161	 	 	 	0.3448	 
	08/01/2010
	 	 	8.1189	 	 	 	6.3947	 	 	 	4.4514	 	 	 	3.4266	 	 	 	2.1045	 	 	 	1.4252	 	 	 	1.0336	 	 	 	0.7860	 	 	 	0.6180	 	 	 	0.4967	 	 	 	0.4047	 	 	 	0.3333	 	 	 	0.2760	 
	08/01/2011
	 	 	7.6703	 	 	 	5.8713	 	 	 	3.8937	 	 	 	2.8880	 	 	 	1.6599	 	 	 	1.0781	 	 	 	0.7651	 	 	 	0.5768	 	 	 	0.4528	 	 	 	0.3642	 	 	 	0.2981	 	 	 	0.2463	 	 	 	0.2045	 
	08/01/2012
	 	 	7.1389	 	 	 	5.2179	 	 	 	3.1789	 	 	 	2.2009	 	 	 	1.1153	 	 	 	0.6732	 	 	 	0.4641	 	 	 	0.3487	 	 	 	0.2752	 	 	 	0.2239	 	 	 	0.1850	 	 	 	0.1537	 	 	 	0.1286	 
	08/01/2013
	 	 	6.5114	 	 	 	4.3505	 	 	 	2.1747	 	 	 	1.2519	 	 	 	0.4402	 	 	 	0.2220	 	 	 	0.1494	 	 	 	0.1150	 	 	 	0.0936	 	 	 	0.0775	 	 	 	0.0651	 	 	 	0.0549	 	 	 	0.0461	 
	08/01/2014
	 	 	6.1592	 	 	 	3.3487	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 

The exact stock price and effective dates may not be set forth on the table, in which case, if the
stock price is:

	 	•	 	between two stock price amounts on the table or the effective date is between two dates
on the table, the number of additional shares will be determined by
straight-line interpolation between the number of additional shares set forth for the
higher and lower stock price amounts and the two dates, as applicable, based on a 360-day
year;
	 
	 	•	 	in excess of $130.00 per share (subject to adjustment), no additional shares will be
issued upon conversion;
	 
	 	•	 	less than $26.78 per share (subject to adjustment), no additional shares will be issued
upon conversion.

Notwithstanding the foregoing, in no event will the conversion rate exceed 37.3412 per $1,000
principal amount of the Debentures, subject to adjustments in the same manner as the conversion
rate.

This communication supplements and amends, and should be read in conjunction with, Global
Industries, Ltd.’s preliminary offering memorandum dated July 23, 2007.

This communication is intended for the sole use of the person to whom it is provided by the sender.

This notice shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall
there be any sale of the debentures or the common stock issuable upon conversion of the debentures
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful. The
debentures will be offered to qualified institutional buyers in reliance on Rule 144A under the
Securities Act of 1933, as amended. The debentures and the shares of common stock issuable upon
conversion of the debentures have not been registered under the Securities Act of 1933 or any state
securities laws, and may not be offered or sold in the United States or to U.S. persons absent
registration or an applicable exemption from the registration requirements.

ANY DISCLAIMER OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND
SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT
OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.

II-2

 

SCHEDULE III

Term sheet containing the terms of the securities, substantially in the form of Schedule II.

III-1

 

Exhibit A

Form of Registration Rights Agreement

A-1

 

Exhibit B

Company Counsel Opinion

     Vinson & Elkins LLP shall have furnished to the Initial Purchasers its written opinion, as
counsel to the Company, addressed to the Initial Purchasers and dated the Closing Date and the
Option Closing Date, in form and substance reasonably satisfactory to Lehman Brothers Inc., to the
effect that:

     (i) No registration under the Securities Act of the Securities is required for the sale
of the Securities to you as contemplated hereby or for the Exempt Resales, assuming (i) the
accuracy of the Initial Purchasers’ representations in this Agreement and (ii) the accuracy
of the Company’s representations contained in this Agreement;

     (ii) The Company has an authorized capitalization as set forth in each of the Pricing
Disclosure Package and the Offering Memorandum. The statements contained in the Pricing
Disclosure Package and the Offering Memorandum under the caption “Description of Capital
Stock” insofar as they purport to constitute a summary of the terms of the Common Stock
(including the Underlying Securities) and the Preferred Stock are accurate in all material
respects;

     (iii) The Company has all requisite corporate power and authority to execute, deliver
and perform its obligations under this Agreement, the Registration Rights Agreement, the
Indenture and the Securities and to issue and sell the Securities;

     (iv) This Agreement has been duly authorized, executed and delivered by the Company;

     (v) The Indenture has been duly authorized, executed and delivered by the Company and,
assuming the due authorization, execution and delivery thereof by the Trustee, is the
legally valid and binding agreement of the Company, enforceable against the Company in
accordance with its terms, except as such enforceability may be limited by bankruptcy,
fraudulent conveyance, insolvency, reorganization, moratorium, and other similar laws
relating to or affecting creditors’ rights generally and by general equitable principles
(regardless of whether such enforceability is considered in a proceeding in equity or at
law) and the implied duty of good faith and fair dealing; no qualification of the Indenture
under the 1939 Act is required in connection with the offer and sale of the Securities or in
connection with the Exempt Resales;

     (vi) The Securities have been duly authorized, executed and issued by the Company and,
assuming due authentication thereof by the Trustee in accordance with the terms of the
Indenture and upon delivery to the Initial Purchasers against payment therefor in accordance
with the terms of this Agreement, will be the legally valid and binding obligations of the
Company, enforceable against the Company in accordance with their terms, except as such
enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency,
reorganization moratorium and other similar laws relating to or

 

 

affecting creditors’ rights generally and by general equitable principles (regardless
of whether such enforceability is considered in a proceeding in equity or at law) and the
implied duty of good faith and fair dealing;

     (vii) The shares of Common Stock, if any, initially issuable upon conversion of the
Securities have been duly authorized and reserved for issuance upon conversion of the
Securities by all necessary corporate action of the Company and, when issued and delivered
upon conversion of the Securities in accordance with the terms of the Indenture, will be
validly issued, fully paid and non-assessable, and the issuance of such shares will not be
subject to any preemptive or similar rights;

     (viii) The Registration Rights Agreement has been duly authorized, executed and
delivered by the Company and, assuming the due authorization, execution and delivery thereof
by the Initial Purchasers, is the legally valid and binding agreement of the Company,
enforceable against the Company in accordance with its terms, except as such enforceability
may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar laws
relating to or affecting creditor’s rights generally, by general equitable principles
(regardless of whether such enforceability is considered in a proceeding in equity or at
law) and, as to rights of indemnification and contribution, by principles of public policy
and the implied duty of good faith and fair dealing;

     (ix) The issue and sale of the Securities, the execution, delivery and performance by
the Company of the Securities, the Indenture, the Registration Rights Agreement and this
Agreement, the application of the proceeds from the sale of the Securities as described
under “Use of Proceeds” in the Pricing Disclosure Package and the Offering Memorandum and
the consummation of the transactions contemplated hereby and thereby, will not (i) conflict
with or result in a breach or violation of any of the terms or provisions of, impose any
lien, charge or encumbrance upon any property or assets of the Company or its subsidiaries,
or constitute a default under, the Company’s Third Amended and Restated Credit Agreement
(the “Credit Agreement”) dated as of June 30, 2006 as amended by Amendment No. 1 thereto
dated as of October 6, 2006 and further amended by amendment No. 2 thereto dated as of July
[___], 2007, among Global Industries, Ltd. and Global Offshore Mexico, S. de R.L. de C.V.,
Global Industries International, L.P., the lenders named in the Credit Agreement and Calyon
New York Branch, as administrative agent for the lenders and issuing bank or any other
contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or any
other agreement or instrument described in or filed as exhibits to the Company’s Annual
Report on Form 10-K for the fiscal year ended on December 31, 2006, or (ii) result in any
violation of the provisions of the charter or by-laws of the Company;

     (x) No consent, approval, authorization, order, registration or qualification with any
Texas or federal court or governmental agency or body having jurisdiction over the Company
is required for the issue and sale of the Securities, the execution, delivery and
performance by the Company of the Securities, the Indenture, the Registration Rights
Agreement and this Agreement, the application of the proceeds from the sale of the
Securities as described under “Use of Proceeds” in the Disclosure Package and the Offering
Memorandum and the consummation of the transactions contemplated hereby

 

 

and thereby, except for (A) the order of the Commission declaring effective the
registration statement required to be filed by the Company with the Commission pursuant to
the Securities Act as required by the Registration Rights Agreement; (B) such as have been
obtained (C) such consents, approvals, authorizations, orders, filings, registrations or
qualifications as may be required under state securities or Blue Sky laws in connection with
the purchase and distribution of the Securities by the Initial Purchasers (as to which such
counsel need not express an opinion); and (D) where the failure to obtain such consents,
approvals, authorizations, orders, registrations or qualifications would not have a Material
Adverse Effect (except that we express no opinion in this paragraph as to compliance with
the registration provisions of the Securities Act of 1933, as amended or the Trust Indenture
Act of 1939, as amended, in relation to the Securities);

     (xi) The Company is not an “investment company” within the meaning of the Investment
Company Act of 1940, as amended;

     (xii) The statements contained in the Pricing Disclosure Package and the Offering
Memorandum under the caption “Description of the Debentures”, insofar as they purport to
constitute a summary of the terms of the Indenture, the Securities and the Registration
Rights Agreement, are accurate in all material respects;

     (xiii) The statements contained in the Pricing Disclosure Package and the Offering
Memorandum under the captions “Description of Certain Indebtedness”, “Certain ERISA
Considerations” and “Plan of Distribution” insofar as they purport to constitute summaries
of the terms of statutes, rules or regulations, legal and governmental proceedings or
contracts and other documents in so far as they purport to constitute summaries of legal
matters and documents are accurate in all material respects; and

     (xiv) The statements contained in the Pricing Disclosure Package and the Offering
Memorandum under the caption “Certain United States Federal Income Tax Considerations,”
insofar as they purport to constitute summaries of matters of United States federal tax law
and regulations or legal conclusions with respect thereto, are accurate in all material
respects.

     In rendering such opinion, such counsel may state that its opinion is limited to matters
governed by the federal laws of the United States of America, the laws of the State of New York
and the Business Corporation Law of the State of Louisiana.

     Such counsel shall also have furnished to the Initial Purchasers a written statement,
addressed to the Initial Purchasers and dated the Closing Date, in form and substance satisfactory
to the Initial Purchasers, to the effect that such counsel has participated in conferences with
representatives of the Company and with representatives of its independent accountants and counsel
at which conferences the contents of the Pricing Disclosure Package and the Offering Memorandum and
related matters were discussed. Although such counsel has not independently verified and are not
passing upon, and do not assume any responsibility for, the accuracy, completeness or fairness of
the statements contained in the Pricing Disclosure Package and the Offering Memorandum (except as
and to the extent set forth in paragraphs (ii), (xii), (xiii) and (xiv)), on the basis of the
foregoing participation (relying with respect to factual matters to the

 

 

extent we deem appropriate upon statements by officers and other representatives of the
Company and the Initial Purchasers), no facts have come to such counsel’s attention that have led
such counsel to believe that: (a) the Pricing Disclosure Package, as of the Applicable Time,
contained any untrue statement of a material fact or omitted to state any material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading; or (b) the Offering Memorandum, as of its date and as of the Closing Date,
contained or contains any untrue statement of a material fact or omitted or omits to state any
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. It being understood that such counsel need express no
opinion, statement or belief with respect to the financial statements, including the notes and
schedules thereto and the auditor’s report there on or any other financial data, contained in or
omitted from the Pricing Disclosure Package and the Offering Memorandum.

 

 

Exhibit C

[Form of Opinion of Russell J. Robicheaux]

     (a) The Company has been duly incorporated and is an existing corporation in good standing
under the laws of the State of Louisiana and has all requisite corporate power and authority to
conduct its business as described in the Pricing Disclosure Package and the Offering Memorandum.

     (b) The Company is duly qualified to do business as a foreign corporation in good standing in
each jurisdiction set forth in Annex A hereto, except where the failure to so qualify or be in good
standing would not result in a Material Adverse Effect.

     (c) Each U.S. Significant Subsidiary (as defined in Rule 405 under the Securities Act of 1933,
as amended) has been duly organized and is validly existing as a corporation or limited liability
company and is in good standing under its jurisdiction of incorporation, and has all requisite
corporate power and authority to own, lease and operate its properties and to conduct its business
as described in the Pricing Disclosure Package and the Offering Memorandum, and is in good standing
in each jurisdiction in which its ownership or lease of property or the conduct of its business
requires such qualification, except where the failure to so qualify or be in good standing would
not result in a Material Adverse Effect.

     (d) Except as otherwise stated in the Pricing Disclosure Package and the Offering Memorandum,
all of the issued and outstanding capital stock of each U.S. Significant Subsidiary has been duly
authorized and is validly issued, fully paid and non-assessable and, to my knowledge, is owned by
the Company, directly or through subsidiaries, free and clear of any security interest, mortgage,
pledge, lien, encumbrance, claim or equity, except for such security interest, mortgage, pledge,
lien, encumbrance, claim or equity created pursuant to that certain Third Amended and Restated
Credit Agreement (the “Credit Agreement”) dated as of June 30, 2006 as amended by Amendment No. 1
thereto dated as of October 6, 2006 and further amended by amendment No. 2 thereto dated as of July
23, 2007, among Global Industries, Ltd. and Global Offshore Mexico, S. de R.L. de C.V., Global
Industries International, L.P., the lenders named in the Credit Agreement and Calyon New York
Branch, as administrative agent for the lenders. None of the outstanding shares of capital stock
of any U.S. Significant Subsidiary was issued in violation of preemptive or other similar rights of
any security holder of such U.S. Significant Subsidiary.

     (e) The authorized, issued and outstanding capital stock of the Company is as set forth in the
Pricing Disclosure Package and the Offering Memorandum.

     (f) The issue and sale of the Securities, the execution, delivery and performance by the
Company of the Securities, the Indenture, the Registration Rights Agreement and this Agreement, the
application of the proceeds from the sale of the Securities as described under “Use of Proceeds” in
the Pricing Disclosure Package and the Offering Memorandum and the consummation of the transactions
contemplated hereby and thereby, will not, whether with or without the giving of notice or passage
of time or both, conflict with or constitute a breach of, or default under, or result in the
creation or imposition of any lien, charge or encumbrance upon any

 

 

property or assets of the Company or any of its Significant Subsidiaries pursuant to any
contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or any other
agreement or instrument, known to such counsel, to which the Company or any of its Significant
Subsidiaries is a party or by which it or any of them may be bound, or to which any of the assets,
properties or operations of the Company or any of its Significant Subsidiaries is subject, except
for conflicts, breaches, defaults, events or liens, charges or encumbrances that would not result
in a Material Adverse Effect, nor will such action result in any violation or the provisions of the
charter or by-laws of the Company or any of its Subsidiaries or any applicable law, statute, rule,
regulation, judgment, order, writ or decree, known to such counsel, of any government, government
instrumentality or court, domestic or foreign, having jurisdiction over the Company or any of its
Significant Subsidiaries or any of their assets, properties or operations.

     (g) To my knowledge and except as described in the Offering Memorandum, there are no legal or
governmental proceedings pending to which the Company or any of its subsidiaries is a party or of
which any property or assets of the Company or any of its subsidiaries is the subject that would,
in the aggregate reasonably be expected to have a Material Adverse Effect; and no such proceedings
are threatened or contemplated by governmental authorities or others.

     The opinions expressed herein are limited to the federal laws of the United States of America
and the Business Corporation Law of the State of Louisiana and I do not express any opinion as to
the laws of any other jurisdiction.

 

 

Exhibit D

[Form of Opinion of Myers & Alberga — Cayman Counsel]

     (i) Each of the Cayman Companies has been duly organized and is validly existing as a company
and is in good standing under the laws of the Cayman Islands. Each of the Cayman Companies has the
requisite corporate power to own or lease its properties and to conduct its business, assuming this
to be the same as that for Global Industries Ltd. as described in the Offering Memorandum.

     (ii) All the issued and outstanding shares of each of the Cayman Companies have been duly
authorized and are validly issued as fully paid and non-assessable and were not issued in violation
of any preemptive rights arising by operation of law or under its Memorandum and Articles of
Association. Based on our review of the Memoranda and Articles of Association and records of the
Cayman Companies, all the issued and outstanding shares of each of them are owned directly by the
Company, a Louisiana limited liability company (to our knowledge, in its capacity as General
Partner of Global Industries International, L.P.). The shares of each of the Cayman Companies have
been charged pursuant to a Foreign Pledge Agreement between (1) Global Industries International,
L.P., the Cayman Companies and (2) Calyon New York Branch dated as of 30th of June 2006.
To our knowledge, none of the issued and outstanding shares of either of the Cayman Companies was
issued in violation of preemptive or similar rights of any person contracting with either of the
Cayman Companies.

 

 

Exhibit E

[Form of Lock-Up Agreements]

LOCK-UP LETTER AGREEMENT

July [___], 2007

Lehman Brothers Inc.

As Representative of the several

Initial Purchasers named in Schedule I

c/o Lehman Brothers Inc.

745 Seventh Avenue

New York, New York 10019

Ladies and Gentlemen:

          The undersigned understands that you and certain other firms (the “Initial Purchasers”)
propose to enter into a Purchase Agreement (the “Purchase Agreement”) to carry out an offering of
$325,000,000 aggregate principal amount of 2.75% Senior Convertible Debentures due 2027 (the
“Securities”) ($375,000,000 if the option to purchase additional Securities is fully exercised)
which will be convertible into cash and in certain circumstances into shares (the “Stock”) of
common stock, par value $0.01 per share (the “Common Stock”), of Global Industries, Ltd.,
a Louisiana corporation (the “Company”), and that the Initial Purchasers propose to reoffer the
Securities to “qualified institutional buyers” under Rule 144A of the Securities Act of 1933, as
amended (the “Offering”).

          In consideration of the efforts of the Initial Purchasers to proceed with the Offering, the
undersigned hereby irrevocably agrees that, without the prior written consent of Lehman Brothers
Inc., on behalf of the Initial Purchasers, the undersigned will not, directly or indirectly, (1)
offer for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device that
is designed to, or could be expected to, result in the disposition by any person at any time in the
future of) any shares of Common Stock (including, without limitation, shares of Common Stock that
may be deemed to be beneficially owned by the undersigned in accordance with the rules and
regulations of the Securities and Exchange Commission and shares of Common Stock that may be issued
upon exercise of any options or warrants) or securities convertible into or exercisable or
exchangeable for Common Stock (other than the Stock), (2) enter into any swap or other derivatives
transaction that transfers to another, in whole or in part, any of the economic benefits or risks
of ownership of shares of Common Stock, whether any such transaction described in clause (1) or (2)
above is to be settled by delivery of Common Stock or other securities, in cash or otherwise, (3)
make any demand for or exercise any right or cause to be filed a registration statement, including
any amendments thereto, with respect to the

 

 

registration of any shares of Common Stock or securities convertible into or exercisable or
exchangeable for Common Stock or any other securities of the Company or (4) publicly disclose the
intention to do any of the foregoing, for a period commencing on the date hereof and ending on the
60th day after the date of the Offering Memorandum relating to the Offering (such 60-day period,
the “Lock-Up Period”).

          Any Securities received upon exercise of options granted to the undersigned will also be
subject to the terms and conditions of this letter agreement (this “Lock-Up Letter
Agreement”). Any Securities acquired by the undersigned in the open market will not be subject
to this Lock-Up Letter Agreement. Transactions executed pursuant to an existing 10b5-1 plan will
not be subject to this Lock-Up Letter Agreement. A transfer of Securities to a family member or
trust may be made, provided the transferee agrees to be bound in writing by the terms of this
Lock-Up Letter Agreement prior to such transfer.

          In furtherance of the foregoing, the Company and its transfer agent are hereby authorized to
decline to make any transfer of securities if such transfer would constitute a violation or breach
of this Lock-Up Letter Agreement.

          It is understood that, if the Company notifies the Initial Purchasers that it does not intend
to proceed with the Offering, if the Purchase Agreement does not become effective, or if the
Purchase Agreement (other than the provisions thereof which survive termination) shall terminate or
be terminated prior to payment for and delivery of the Stock, the undersigned will be released from
its obligations under this Lock-Up Letter Agreement.

          The undersigned understands that the Company and the Initial Purchasers will proceed
with the Offering in reliance on this Lock-Up Letter Agreement.

          Whether or not the Offering actually occurs depends on a number of factors, including market
conditions. Any Offering will only be made pursuant to a Purchase Agreement, the terms of which
are subject to negotiation between the Company, and the Initial Purchasers.

[Signature page follows]

2

 

          The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Lock-Up Letter Agreement and that, upon request, the undersigned will
execute any additional documents necessary in connection with the enforcement hereof. Any
obligations of the undersigned shall be binding upon the heirs, personal representatives,
successors and assigns of the undersigned.

	 	 	 	 	 
	 	Very truly yours,

 	 
	 	By:  	 	 
	 	 	Name:  	 	 	 
	 	 	Title:  	 	 	 
	Dated: _______________ 	 

3

 

	 	 	 	 	 

Schedule I

Lehman Brothers Inc.

Calyon Securities (USA) Inc.

Natexis Bleichroeder Inc.

Fortis Securities LLC.

1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]